% alzhub.org library filter
% Source: https://alzhub.org/research?design=trial
% 347 entries, in the order the page lists them. Built from alzhub.org's own records.
% 3 entries have no readable author in the source record and carry no author field.

@article{pascuallucas2025-41058018,
  author  = {Pascual-Lucas, M. and Lacosta, A. M. and Montañés, M. and Canudas, J. and Loscos, J. and Monleón, I. and Allué, J. A. and Sarasa, L. and others},
  title   = {{Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70776},
  pmid    = {41058018},
  url     = {https://doi.org/10.1002/alz.70776}
}

@article{asada2025-40302041,
  author  = {Asada, Takashi and Thanasopoulou, Angeliki and Delmar, Paul and Wojtowicz, Jakub and Smith, Janice and Yoshiyama, Yasumasa and Yokoi, Katsunori and Watanabe, Chigusa and others},
  title   = {{Japanese participant data from three gantenerumab trials in early Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70192},
  pmid    = {40302041},
  url     = {https://doi.org/10.1002/alz.70192}
}

@article{salloway2025-40390253,
  author  = {Salloway, S. and Pain, A. and Lee, E. and Papka, M. and Ferguson, M. B. and Wang, H. and Hu, H. and Lu, M. and others},
  title   = {{TRAILBLAZER-ALZ 4: A phase 3 trial comparing donanemab with aducanumab on amyloid plaque clearance in early, symptomatic Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70293},
  pmid    = {40390253},
  url     = {https://doi.org/10.1002/alz.70293}
}

@article{vijverberg2026-41930592,
  author  = {Vijverberg, Everard G B and Scharre, Douglas W and Woodward, Michael and Catalano, Susan and Hamby, Mary E and Grundman, Michael and Morgan, Roger E and Iaci, Jennifer and others},
  title   = {{Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2026},
  doi     = {10.1177/13872877261437145},
  pmid    = {41930592},
  url     = {https://doi.org/10.1177/13872877261437145}
}

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{holper2026-41980907,
  author  = {Holper, Sarah and Barnham, Kevin J and Churilov, Leonid and Yates, Paul and Brodtmann, Amy and Johns, Sally and Li, Qia-Xin and Bhalala, Oneil and others},
  title   = {{A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71381},
  pmid    = {41980907},
  url     = {https://doi.org/10.1002/alz.71381}
}

@article{burns2021-34146512,
  author  = {Burns, Daniel K and Alexander, Robert C and Welsh-Bohmer, Kathleen A and Culp, Meredith and Chiang, Carl and O'Neil, Janet and Evans, Rebecca M and Harrigan, Patrick and others},
  title   = {{Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00043-0},
  pmid    = {34146512},
  url     = {https://doi.org/10.1016/s1474-4422(21)00043-0}
}

@article{macfarlane2025-39800452,
  author  = {Macfarlane, S. and Grimmer, T. and Teo, K. and O'Brien, T. J. and Woodward, M. and Grunfeld, J. and Mander, A. and Brodtmann, A. and others},
  title   = {{Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2024.100016},
  pmid    = {39800452},
  url     = {https://doi.org/10.1016/j.tjpad.2024.100016}
}

@article{toda2024-39350371,
  author  = {Toda, Y. and Iwatsubo, T. and Nakamura, Y. and Matsuda, N. and Miyata, M. and Jin, M. and Chen, T. and Kuribayashi, K. and others},
  title   = {{Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.106},
  pmid    = {39350371},
  url     = {https://doi.org/10.14283/jpad.2024.106}
}

@article{nisenbaum2023-36795603,
  author  = {Nisenbaum, Laura and Martone, Robert and Chen, Tianle and Rajagovindan, Rajasimhan and Dent, Gersham and Beaver, John and Rubel, Carrie and Racine, Annie and others},
  title   = {{CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12919},
  pmid    = {36795603},
  url     = {https://doi.org/10.1002/alz.12919}
}

@article{abdelhaleem2026-40435316,
  author  = {Abdel-Haleem, Alyaa M and Casavant, Ellen and Toth, Balazs and Teng, Edmond and Monteiro, Cecilia and Pandya, Nikhil J and Glock, Caspar and Hoogenraad, Casper C and others},
  title   = {{CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures}},
  journal = {Brain : a journal of neurology},
  year    = {2026},
  doi     = {10.1093/brain/awaf200},
  pmid    = {40435316},
  url     = {https://doi.org/10.1093/brain/awaf200}
}

@article{zimmer2025-40063015,
  author  = {Zimmer, J. A. and Ardayfio, P. and Wang, H. and Khanna, R. and Evans, C. D. and Lu, M. and Sparks, J. and Andersen, S. and Lauzon, S. and Nery, E. S. M. and others},
  title   = {{Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials}},
  journal = {JAMA Neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0065},
  pmid    = {40063015},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0065}
}

@article{salloway2022-34807243,
  author  = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4161},
  pmid    = {34807243},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4161}
}

@article{bateman2025-40120616,
  author  = {Bateman, Randall J and Li, Yan and McDade, Eric M and Llibre-Guerra, Jorge J and Clifford, David B and Atri, Alireza and Mills, Susan L and Santacruz, Anna M and others},
  title   = {{Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial}},
  journal = {The Lancet. Neurology},
  year    = {2025},
  doi     = {10.1016/s1474-4422(25)00024-9},
  pmid    = {40120616},
  url     = {https://doi.org/10.1016/s1474-4422(25)00024-9}
}

@article{perry2026-41689888,
  author  = {Perry, Richard and Kipps, Christopher and Martín, Maria Eugenia Soto and Bozzali, Marco and Logroscino, Giancarlo and Trafford, Sarah and Dhadda, Shobha and Kanekiyo, Michio and others},
  title   = {{Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100507},
  pmid    = {41689888},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100507}
}

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{honig2018-29365294,
  author  = {Honig, L. S. and Vellas, B. and Woodward, M. and Boada, M. and Bullock, R. and Borrie, M. and Hager, K. and Andreasen, N. and others},
  title   = {{Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2018},
  doi     = {10.1056/nejmoa1705971},
  pmid    = {29365294},
  url     = {https://doi.org/10.1056/nejmoa1705971}
}

@article{florian2023-36730056,
  author  = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others},
  title   = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad024},
  pmid    = {36730056},
  url     = {https://doi.org/10.1093/brain/awad024}
}

@article{costa2022-34942135,
  author  = {Costa, Alberto C S and Brandão, Ana C and Boada, Richard and Barrionuevo, Veridiana L and Taylor, Hudson G and Roth, Elizabeth and Stasko, Melissa R and Johnson, Mark W and others},
  title   = {{Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(21)00369-0},
  pmid    = {34942135},
  url     = {https://doi.org/10.1016/s1474-4422(21)00369-0}
}

@article{cummings2026-c800c391,
  author  = {Cummings, J. L. and Atri, A. and Scheltens, P. and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (EVOKE and EVOKE+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{turner2015-26362286,
  author  = {Turner, R. S. and Thomas, R. G. and Craft, S. and van Dyck, C. H. and Mintzer, J. and Reynolds, B. A. and Brewer, J. B. and Rissman, R. A. and others},
  title   = {{A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000002035},
  pmid    = {26362286},
  url     = {https://doi.org/10.1212/wnl.0000000000002035}
}

@article{ostrowitzki2022-36121669,
  author  = {Ostrowitzki, S. and Bittner, T. and Sink, K. M. and Mackey, H. and Rabe, C. and Honig, L. S. and Cassetta, E. and Woodward, M. and others},
  title   = {{Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2909},
  pmid    = {36121669},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2909}
}

@article{bateman2023-37966285,
  author  = {Bateman, R. J. and Smith, J. and Donohue, M. C. and Delmar, P. and Abbas, R. and Salloway, S. and Wojtowicz, J. and Blennow, K. and others},
  title   = {{Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2304430},
  pmid    = {37966285},
  url     = {https://doi.org/10.1056/nejmoa2304430}
}

@article{swanson2021-33865446,
  author  = {Swanson, C. J. and Zhang, Y. and Dhadda, S. and Wang, J. and Kaplow, J. and Lai, R. Y. K. and Lannfelt, L. and Bradley, H. and others},
  title   = {{A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00813-8},
  pmid    = {33865446},
  url     = {https://doi.org/10.1186/s13195-021-00813-8}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{mcdade2022-36544184,
  author  = {McDade, E. and Cummings, J. L. and Dhadda, S. and Swanson, C. J. and Reyderman, L. and Kanekiyo, M. and Koyama, A. and Irizarry, M. and others},
  title   = {{Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-01124-2},
  pmid    = {36544184},
  url     = {https://doi.org/10.1186/s13195-022-01124-2}
}

@article{greeley2025-40912996,
  author  = {Greeley, David and Nash, Marshall and Herskowitz, Brad and Kim, Fred and Rock, James and Prins, Neils and Kim, SangYun and Xi, Tianyang and others},
  title   = {{A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100337},
  pmid    = {40912996},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100337}
}

@article{green2009-20009055,
  author  = {Green, R. C. and Schneider, L. S. and Amato, D. A. and Beelen, A. P. and Wilcock, G. and Swabb, E. A. and Zavitz, K. H. and {Tarenflurbil Phase 3 Study Group}},
  title   = {{Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1866},
  pmid    = {20009055},
  url     = {https://doi.org/10.1001/jama.2009.1866}
}

@article{vandyck2023-36449413,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and others},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2212948},
  pmid    = {36449413},
  url     = {https://doi.org/10.1056/nejmoa2212948}
}

@article{wilkinson2014-25297016,
  author  = {Wilkinson, David and Windfeld, Kristian and Colding-Jørgensen, Eskild},
  title   = {{Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2014},
  doi     = {10.1016/s1474-4422(14)70198-x},
  pmid    = {25297016},
  url     = {https://doi.org/10.1016/s1474-4422(14)70198-x}
}

@article{mintun2021-33720637,
  author  = {Mintun, M. A. and Lo, A. C. and Duggan Evans, C. and Wessels, A. M. and Ardayfio, P. A. and Andersen, S. W. and Shcherbinin, S. and Sparks, J. and others},
  title   = {{Donanemab in Early Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2021},
  doi     = {10.1056/nejmoa2100708},
  pmid    = {33720637},
  url     = {https://doi.org/10.1056/nejmoa2100708}
}

@article{sperling2023-37458272,
  author  = {Sperling, R. A. and Donohue, M. C. and Raman, R. and Rafii, M. S. and Johnson, K. and Masters, C. L. and van Dyck, C. H. and Iwatsubo, T. and others},
  title   = {{Trial of Solanezumab in Preclinical Alzheimer's Disease}},
  journal = {The New England journal of medicine},
  year    = {2023},
  doi     = {10.1056/nejmoa2305032},
  pmid    = {37458272},
  url     = {https://doi.org/10.1056/nejmoa2305032}
}

@article{cury2025-41160460,
  author  = {Cury, Rafael de Morais and da Silva, Taynara and Cezar-Dos-Santos, Fernando and Fakih, Yasmin Rafaela Correia and Narvaez, Karlin Andrea Ramírez and Gouvea, Murilo Chaves and Espínola, Carlos and Ferreira, Charles Francisco and others},
  title   = {{A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251389608},
  pmid    = {41160460},
  url     = {https://doi.org/10.1177/13872877251389608}
}

@article{sauder2022-36414626,
  author  = {Sauder, Colin and Allen, Luke A and Baker, Elizabeth and Miller, Andrew C and Paul, Steven M and Brannan, Stephen K},
  title   = {{Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study}},
  journal = {Translational psychiatry},
  year    = {2022},
  doi     = {10.1038/s41398-022-02254-9},
  pmid    = {36414626},
  url     = {https://doi.org/10.1038/s41398-022-02254-9}
}

@article{edison2025-41326666,
  author  = {Edison, P. and Femminella, G. D. and Ritchie, C. and Nowell, J. and Holmes, C. and Walker, Z. and Ridha, B. and Raza, S. and Livingston, N. R. and Frangou, E. and others},
  title   = {{Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-04106-7},
  pmid    = {41326666},
  url     = {https://doi.org/10.1038/s41591-025-04106-7}
}

@article{honig2024-38730496,
  author  = {Honig, L. S. and Sabbagh, M. N. and van Dyck, C. H. and Sperling, R. A. and Hersch, S. and Matta, A. and Giorgi, L. and Gee, M. and others},
  title   = {{Updated safety results from phase 3 lecanemab study in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01441-8},
  pmid    = {38730496},
  url     = {https://doi.org/10.1186/s13195-024-01441-8}
}

@article{wessels2020-31764959,
  author  = {Wessels, A. M. and Tariot, P. N. and Zimmer, J. A. and Selzler, K. J. and Bragg, S. M. and Andersen, S. W. and Landry, J. and Krull, J. H. and others},
  title   = {{Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3988},
  pmid    = {31764959},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3988}
}

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{henderson2016-26795874,
  author  = {Henderson, E. J. and Lord, SR. and Brodie, M. A. and Gaunt, D. M. and Lawrence, A. D. and Close, J. C. and Whone, A. L. and others},
  title   = {{Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2016},
  doi     = {10.1016/s1474-4422(15)00389-0},
  pmid    = {26795874},
  url     = {https://doi.org/10.1016/s1474-4422(15)00389-0}
}

@article{novak2017-27955995,
  author  = {Novak, P. and Schmidt, R. and Kontsekova, E. and Zilka, N. and Kovacech, B. and Skrabana, R. and Vince-Kazmerova, Z. and Katina, S. and others},
  title   = {{Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial}},
  journal = {The Lancet. Neurology},
  year    = {2017},
  doi     = {10.1016/s1474-4422(16)30331-3},
  pmid    = {27955995},
  url     = {https://doi.org/10.1016/s1474-4422(16)30331-3}
}

@article{koh2021-33771205,
  author  = {Koh, Seong-Ho and Kwon, Hyuk Sung and Choi, Seong Hye and Jeong, Jee Hyang and Na, Hae Ri and Lee, Chan Nyoung and Yang, YoungSoon and Lee, Ae Young and others},
  title   = {{Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00803-w},
  pmid    = {33771205},
  url     = {https://doi.org/10.1186/s13195-021-00803-w}
}

@article{craft2020-32568367,
  author  = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others},
  title   = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1840},
  pmid    = {32568367},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1840}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{salloway2018-30129411,
  author  = {Salloway, S. and Marshall, G. A. and Lu, M. and Brashear, H. R.},
  title   = {{Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase 2, Open-Label Extension Study}},
  journal = {Current Alzheimer research},
  year    = {2018},
  doi     = {10.2174/1567205015666180821114813},
  pmid    = {30129411},
  url     = {https://doi.org/10.2174/1567205015666180821114813}
}

@article{neve2024-39177596,
  author  = {Neve, A. and Das, B. and Wojtowicz, J. and Huang, Z. and Bullain, S. and Watkin, M. and Lott, D. and Bittner, T. and others},
  title   = {{Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2024},
  doi     = {10.3233/jad-240221},
  pmid    = {39177596},
  url     = {https://doi.org/10.3233/jad-240221}
}

@article{holmes2004-15277611,
  author  = {Holmes, C. and Wilkinson, D. and Dean, C. and Vethanayagam, S. and Olivieri, S. and Langley, A. and Pandita-Gunawardena, N. D. and Hogg, F. and others},
  title   = {{The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000129990.32253.7b},
  pmid    = {15277611},
  url     = {https://doi.org/10.1212/01.wnl.0000129990.32253.7b}
}

@article{boess2024-38706270,
  author  = {Boess, F G and Scelsi, M A and Grimmer, T and Perry, R J and Tonietto, M and Klein, G and Hofmann, C and Salami, M and others},
  title   = {{At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.60},
  pmid    = {38706270},
  url     = {https://doi.org/10.14283/jpad.2024.60}
}

@article{nordberg2009-19199870,
  author  = {Nordberg, Agneta and Darreh-Shori, Taher and Peskind, Elaine and Soininen, Hilkka and Mousavi, Malahat and Eagle, Gina and Lane, Roger},
  title   = {{Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients}},
  journal = {Current Alzheimer research},
  year    = {2009},
  doi     = {10.2174/156720509787313961},
  pmid    = {19199870},
  url     = {https://doi.org/10.2174/156720509787313961}
}

@article{wang2025-40172303,
  author  = {Wang, H. and Serap Monkul Nery, E. and Ardayfio, P. and Khanna, R. and Otero Svaldi, D. and Gueorguieva, I. and Shcherbinin, S. and Andersen, S. W. and Hauck, P. M. and Engle, S. E. and others},
  title   = {{Modified titration of donanemab reduces ARIA risk and maintains amyloid reduction}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70062},
  pmid    = {40172303},
  url     = {https://doi.org/10.1002/alz.70062}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{shcherbinin2022-36094645,
  author  = {Shcherbinin, S. and Evans, C. D. and Lu, M. and Andersen, S. W. and Pontecorvo, M. J. and Willis, B. A. and Gueorguieva, I. and Hauck, P. M. and others},
  title   = {{Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.2793},
  pmid    = {36094645},
  url     = {https://doi.org/10.1001/jamaneurol.2022.2793}
}

@article{han2017-28587629,
  author  = {Han, J. W. and Son, K. L. and Byun, H. J. and Ko, J. W. and Kim, K. and Hong, J. W. and Kim, T. H. and Kim, K. W.},
  title   = {{Efficacy of the Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (USMART) program among patients with mild cognitive impairment: a randomized controlled crossover trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2017},
  doi     = {10.1186/s13195-017-0264-8},
  pmid    = {28587629},
  url     = {https://doi.org/10.1186/s13195-017-0264-8}
}

@article{farlow2012-22672770,
  author  = {Farlow, M. and Arnold, S. E. and van Dyck, C. H. and Aisen, P. S. and Snider, B. J. and Porsteinsson, A. P. and Friedrich, S. and Dean, R. A. and others},
  title   = {{Safety and biomarker effects of solanezumab in patients with Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2012},
  doi     = {10.1016/j.jalz.2011.09.224},
  pmid    = {22672770},
  url     = {https://doi.org/10.1016/j.jalz.2011.09.224}
}

@article{yaxley2016-27474375,
  author  = {Yaxley, J. W. and Coughlin, G. D. and Chambers, S. K. and Occhipinti, S. and Samaratunga, H. and Zajdlewicz, L. and Dunglison, N. and Carter, R. and others},
  title   = {{Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study}},
  journal = {Lancet (London, England)},
  year    = {2016},
  doi     = {10.1016/s0140-6736(16)30592-x},
  pmid    = {27474375},
  url     = {https://doi.org/10.1016/s0140-6736(16)30592-x}
}

@article{abushakra2017-29182706,
  author  = {Abushakra, S and Porsteinsson, A and Scheltens, P and Sadowsky, C and Vellas, B and Cummings, J and Gauthier, S and Hey, J A and others},
  title   = {{Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2017},
  doi     = {10.14283/jpad.2017.26},
  pmid    = {29182706},
  url     = {https://doi.org/10.14283/jpad.2017.26}
}

@article{relkin2017-28381506,
  author  = {Relkin, Norman R and Thomas, Ronald G and Rissman, Robert A and Brewer, James B and Rafii, Michael S and van Dyck, Christopher H and Jack, Clifford R and Sano, Mary and others},
  title   = {{A phase 3 trial of IV immunoglobulin for Alzheimer disease}},
  journal = {Neurology},
  year    = {2017},
  doi     = {10.1212/wnl.0000000000003904},
  pmid    = {28381506},
  url     = {https://doi.org/10.1212/wnl.0000000000003904}
}

@article{cummings2015-26393847,
  author  = {Cummings, J. L. and Lyketsos, C. G. and Peskind, E. R. and Porsteinsson, A. P. and Mintzer, J. E. and Scharre, D. W. and De La Gandara, J. E. and Agronin, M. and others},
  title   = {{Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2015},
  doi     = {10.1001/jama.2015.10214},
  pmid    = {26393847},
  url     = {https://doi.org/10.1001/jama.2015.10214}
}

@article{cohen2023-37874099,
  author  = {Cohen, S and van Dyck, C H and Gee, M and Doherty, T and Kanekiyo, M and Dhadda, S and Li, D and Hersch, S and others},
  title   = {{Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2023.123},
  pmid    = {37874099},
  url     = {https://doi.org/10.14283/jpad.2023.123}
}

@article{vandyck2023-22dd8fce,
  author  = {van Dyck, C. H. and Swanson, C. J. and Aisen, P. and Bateman, R. J. and Chen, C. and Gee, M. and Kanekiyo, M. and Li, D. and Reyderman, L. and Cohen, S. and Froelich, L. and Katayama, S. and Sabbagh, M. and Vellas, B. and Watson, D. and Dhadda, S. and Irizarry, M. and Kramer, L. D. and Iwatsubo, T.},
  title   = {{Lecanemab in Early Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2023},
  pmid    = {36449413}
}

@article{sims2023-9857475c,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and Wang, H. and Monkul Nery, E. S. and Collins, E. C. and Solomon, P. and Salloway, S. and Apostolova, L. G. and Hansson, O. and Ritchie, C. and Brooks, D. A. and Mintun, M. and Skovronsky, D. M. and {TRAILBLAZER-ALZ 2 Investigators}},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  pmid    = {37459141}
}

@article{rajji2025-40133524,
  author  = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others},
  title   = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}},
  journal = {Nature Medicine},
  year    = {2025},
  doi     = {10.1038/s41591-025-03569-y},
  pmid    = {40133524},
  url     = {https://doi.org/10.1038/s41591-025-03569-y}
}

@article{salloway2009-19923550,
  author  = {Salloway, S. and Sperling, R. and Gilman, S. and Fox, N. C. and Blennow, K. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181c67808},
  pmid    = {19923550},
  url     = {https://doi.org/10.1212/wnl.0b013e3181c67808}
}

@article{coric2012-22892585,
  author  = {Coric, V. and van Dyck, C. H. and Salloway, S. and Andreasen, N. and Brody, M. and Richter, R. W. and Soininen, H. and Thein, S. and others},
  title   = {{Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.2194},
  pmid    = {22892585},
  url     = {https://doi.org/10.1001/archneurol.2012.2194}
}

@article{sims2023-37459141,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and others},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  doi     = {10.1001/jama.2023.13239},
  pmid    = {37459141},
  url     = {https://doi.org/10.1001/jama.2023.13239}
}

@article{cummings2018-29695589,
  author  = {Cummings, J. L. and Cohen, S. and van Dyck, C. H. and Brody, M. and Curtis, C. and Cho, W. and Ward, M. and Friesenhahn, M. and others},
  title   = {{ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000005550},
  pmid    = {29695589},
  url     = {https://doi.org/10.1212/wnl.0000000000005550}
}

@article{monteiro2023-37643887,
  author  = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and others},
  title   = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207663},
  pmid    = {37643887},
  url     = {https://doi.org/10.1212/wnl.0000000000207663}
}

@article{raskind2000-10881250,
  author  = {Raskind, M. A. and Peskind, E. R. and Wessel, T. and Yuan, W.},
  title   = {{Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group}},
  journal = {Neurology},
  year    = {2000},
  doi     = {10.1212/wnl.54.12.2261},
  pmid    = {10881250},
  url     = {https://doi.org/10.1212/wnl.54.12.2261}
}

@article{xiao2021-33731209,
  author  = {Xiao, S. and Chan, P. and Wang, T. and Hong, Z. and Wang, S. and Kuang, W. and He, J. and Pan, X. and others},
  title   = {{A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00795-7},
  pmid    = {33731209},
  url     = {https://doi.org/10.1186/s13195-021-00795-7}
}

@article{ornish2024-38849944,
  author  = {Ornish, D. and Madison, C. and Kivipelto, M. and Kemp, C. and McCulloch, C. E. and Galasko, D. and Artz, J. and Rentz, D. and others},
  title   = {{Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01482-z},
  pmid    = {38849944},
  url     = {https://doi.org/10.1186/s13195-024-01482-z}
}

@article{prins2021-34044875,
  author  = {Prins, N. D. and Harrison, J. E. and Chu, H. M. and Blackburn, K. and Alam, J. J. and Scheltens, P. and {REVERSE-SD Study Investigators}},
  title   = {{A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00843-2},
  pmid    = {34044875},
  url     = {https://doi.org/10.1186/s13195-021-00843-2}
}

@article{richard2016-27288376,
  author  = {Richard, E. and Jongstra, S. and Soininen, H. and Brayne, C. and Moll van Charante, E. P. and Meiller, Y. and van der Groep, B. and Beishuizen, C. R. and others},
  title   = {{Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment}},
  journal = {BMJ open},
  year    = {2016},
  doi     = {10.1136/bmjopen-2015-010806},
  pmid    = {27288376},
  url     = {https://doi.org/10.1136/bmjopen-2015-010806}
}

@article{delnomdedieu2016-26925577,
  author  = {Delnomdedieu, M. and Duvvuri, S. and Li, D. J. and Atassi, N. and Lu, M. and Brashear, H. R. and Liu, E. and Ness, S. and others},
  title   = {{First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0177-y},
  pmid    = {26925577},
  url     = {https://doi.org/10.1186/s13195-016-0177-y}
}

@article{gold2010-20733306,
  author  = {Gold, M. and Alderton, C. and Zvartau-Hind, M. and Egginton, S. and Saunders, A. M. and Irizarry, M. and Craft, S. and Landreth, G. and others},
  title   = {{Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2010},
  doi     = {10.1159/000318845},
  pmid    = {20733306},
  url     = {https://doi.org/10.1159/000318845}
}

@article{mummery2026-41787076,
  author  = {Mummery, C. J. and Mayorga, A. J. and Simmons, A. and Chow, T. W. and Burgess, B. and Nguyen, T. and Gao, J. and Budda, B. and Park, L. Q. and Gupta, R. and Li, C. and Shi, L. and others},
  title   = {{The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial}},
  journal = {Nature Medicine},
  year    = {2026},
  doi     = {10.1038/s41591-026-04273-1},
  pmid    = {41787076},
  url     = {https://doi.org/10.1038/s41591-026-04273-1}
}

@article{tsai2020-31710340,
  author  = {Tsai, R. M. and Miller, Z. and Koestler, M. and Rojas, J. C. and Ljubenkov, P. A. and Rosen, H. J. and Rabinovici, G. D. and Fagan, A. M. and others},
  title   = {{Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2019.3812},
  pmid    = {31710340},
  url     = {https://doi.org/10.1001/jamaneurol.2019.3812}
}

@article{baker2025-40271888,
  author  = {Baker, L. D. and Pa, J. A. and Katula, J. A. and Aslanyan, V. and Salmon, D. P. and Jacobs, D. M. and Chmelo, E. A. and Hodge, H. and Morrison, R. and Matthews, G. and others},
  title   = {{Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14586},
  pmid    = {40271888},
  url     = {https://doi.org/10.1002/alz.14586}
}

@article{devanand2026-41405855,
  author  = {Devanand, D P and Wisniewski, Thomas and Razlighi, Qolamreza and Qian, Min and Wei, Renjie and Andrews, Howard F and Acosta, Edward P and Bell, Karen L and others},
  title   = {{Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2025.21738},
  pmid    = {41405855},
  url     = {https://doi.org/10.1001/jama.2025.21738}
}

@article{fleisher2024-38386949,
  author  = {Fleisher, A. S. and Munsie, L. M. and Perahia, D. G. S. and Andersen, S. W. and Higgins, I. A. and Hauck, P. M. and Lo, A. C. and Sims, JR. and others},
  title   = {{Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000208061},
  pmid    = {38386949},
  url     = {https://doi.org/10.1212/wnl.0000000000208061}
}

@article{ritchie2003-14676042,
  author  = {Ritchie, C. W. and Bush, A. I. and Mackinnon, A. and Macfarlane, S. and Mastwyk, M. and MacGregor, L. and Kiers, L. and Cherny, R. and others},
  title   = {{Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial}},
  journal = {Archives of neurology},
  year    = {2003},
  doi     = {10.1001/archneur.60.12.1685},
  pmid    = {14676042},
  url     = {https://doi.org/10.1001/archneur.60.12.1685}
}

@article{rogers1998-9588436,
  author  = {Rogers, S. L. and Doody, R. S. and Mohs, R. C. and Friedhoff, L. T.},
  title   = {{Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group}},
  journal = {Archives of internal medicine},
  year    = {1998},
  doi     = {10.1001/archinte.158.9.1021},
  pmid    = {9588436},
  url     = {https://doi.org/10.1001/archinte.158.9.1021}
}

@article{sha2019-30383097,
  author  = {Sha, S. J. and Deutsch, G. K. and Tian, L. and Richardson, K. and Coburn, M. and Gaudioso, J. L. and Marcal, T. and Solomon, E. and others},
  title   = {{Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3288},
  pmid    = {30383097},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3288}
}

@article{mori2012-22829268,
  author  = {Mori, E. and Ikeda, M. and Kosaka, K. and {Donepezil-DLB Study Investigators}},
  title   = {{Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial}},
  journal = {Annals of neurology},
  year    = {2012},
  doi     = {10.1002/ana.23557},
  pmid    = {22829268},
  url     = {https://doi.org/10.1002/ana.23557}
}

@article{cummings2026-41865758,
  author  = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{mummery2023-37095250,
  author  = {Mummery, C. J. and Börjesson-Hanson, A. and Blackburn, D. J. and Vijverberg, E. G. B. and De Deyn, P. P. and Ducharme, S. and Jonsson, M. and Schneider, A. and Rinne, J. O. and Ludolph, A. C. and Bodenschatz, R. and Kordasiewicz, H. and others},
  title   = {{Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial}},
  journal = {Nature Medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02326-3},
  pmid    = {37095250},
  url     = {https://doi.org/10.1038/s41591-023-02326-3}
}

@article{singh2024-39432286,
  author  = {Singh, S. and Li, X. and Cocoros, N. M. and Antonelli, M. T. and Avula, R. and Crawford, S. L. and Dashevsky, I. and Fouayzi, H. and others},
  title   = {{High-Risk Medications in Persons Living With Dementia: A Randomized Clinical Trial}},
  journal = {JAMA internal medicine},
  year    = {2024},
  doi     = {10.1001/jamainternmed.2024.5632},
  pmid    = {39432286},
  url     = {https://doi.org/10.1001/jamainternmed.2024.5632}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{long2024-39444037,
  author  = {Long, H. and Simmons, A. and Mayorga, A. and Burgess, B. and Nguyen, T. and Budda, B. and Rychkova, A. and Rhinn, H. and others},
  title   = {{Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01599-1},
  pmid    = {39444037},
  url     = {https://doi.org/10.1186/s13195-024-01599-1}
}

@article{sevigny2024-38745011,
  author  = {Sevigny, J. and Uspenskaya, O. and Heckman, L. D. and Wong, L. C. and Hatch, D. A. and Tewari, A. and Vandenberghe, R. and Irwin, D. J. and others},
  title   = {{Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results}},
  journal = {Nature medicine},
  year    = {2024},
  doi     = {10.1038/s41591-024-02973-0},
  pmid    = {38745011},
  url     = {https://doi.org/10.1038/s41591-024-02973-0}
}

@article{morato2023-37012306,
  author  = {Morató, X. and Marquié, M. and Tartari, J. P. and Lafuente, A. and Abdelnour, C. and Alegret, M. and Jofresa, S. and Buendía, M. and others},
  title   = {{A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress}},
  journal = {Scientific reports},
  year    = {2023},
  doi     = {10.1038/s41598-023-32515-6},
  pmid    = {37012306},
  url     = {https://doi.org/10.1038/s41598-023-32515-6}
}

@article{knopman2023-37295957,
  author  = {Knopman, D. S. and Hershey, L.},
  title   = {{Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207438},
  pmid    = {37295957},
  url     = {https://doi.org/10.1212/wnl.0000000000207438}
}

@article{cantoni2025-41359335,
  author  = {Cantoni, V. and Casula, E. P. and Tarantino, B. and Cupidi, C. and Huber, N. and Altomare, D. and Premi, E. and Zummo, E. and others},
  title   = {{Home-Based Gamma Transcranial Alternating Current Stimulation in Patients With Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2025.46556},
  pmid    = {41359335},
  url     = {https://doi.org/10.1001/jamanetworkopen.2025.46556}
}

@article{barthel2011-21481640,
  author  = {Barthel, H. and Gertz, H. J. and Dresel, S. and Peters, O. and Bartenstein, P. and Buerger, K. and Hiemeyer, F. and Wittemer-Rump, S. M. and others},
  title   = {{Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study}},
  journal = {The Lancet. Neurology},
  year    = {2011},
  doi     = {10.1016/s1474-4422(11)70077-1},
  pmid    = {21481640},
  url     = {https://doi.org/10.1016/s1474-4422(11)70077-1}
}

@article{geldmacher2003-12834513,
  author  = {Geldmacher, D. S. and Provenzano, G. and McRae, T. and Mastey, V. and Ieni, JR.},
  title   = {{Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2003},
  doi     = {10.1046/j.1365-2389.2003.51306.x},
  pmid    = {12834513},
  url     = {https://doi.org/10.1046/j.1365-2389.2003.51306.x}
}

@article{siemers2016-26238576,
  author  = {Siemers, E. R. and Sundell, K. L. and Carlson, C. and Case, M. and Sethuraman, G. and Liu-Seifert, H. and Dowsett, S. A. and Pontecorvo, M. J. and others},
  title   = {{Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2016},
  doi     = {10.1016/j.jalz.2015.06.1893},
  pmid    = {26238576},
  url     = {https://doi.org/10.1016/j.jalz.2015.06.1893}
}

@article{coleman2025-39862881,
  author  = {Coleman, K. K. L. and Berry, S. and Cummings, J. and Hsiung, G. R. and Laforce, R. and Huey, E. and Ducharme, S. and Tartaglia, M. C. and Mendez, M. F. and Onyike, C. and others},
  title   = {{Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial}},
  journal = {The Lancet Neurology},
  year    = {2025},
  doi     = {10.1016/S1474-4422(24)00456-3},
  pmid    = {39862881},
  url     = {https://doi.org/10.1016/S1474-4422(24)00456-3}
}

@article{salloway2011-21917766,
  author  = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others},
  title   = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e3182309fa5},
  pmid    = {21917766},
  url     = {https://doi.org/10.1212/wnl.0b013e3182309fa5}
}

@article{rafii2018-29582053,
  author  = {Rafii, M. S. and Tuszynski, M. H. and Thomas, R. G. and Barba, D. and Brewer, J. B. and Rissman, R. A. and Siffert, J. and Aisen, P. S. and others},
  title   = {{Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2018},
  doi     = {10.1001/jamaneurol.2018.0233},
  pmid    = {29582053},
  url     = {https://doi.org/10.1001/jamaneurol.2018.0233}
}

@article{schneider2019-31492718,
  author  = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}},
  title   = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008239},
  pmid    = {31492718},
  url     = {https://doi.org/10.1212/wnl.0000000000008239}
}

@article{saito2023-38048134,
  author  = {Saito, S. and Suzuki, K. and Ohtani, R. and Maki, T. and Kowa, H. and Tachibana, H. and Washida, K. and Kawabata, N. and others},
  title   = {{Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.44938},
  pmid    = {38048134},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.44938}
}

@article{jeong2022-36038268,
  author  = {Jeong, S. Y. and Suh, C. H. and Shim, W. H. and Lim, J. S. and Lee, J. H. and Kim, S. J.},
  title   = {{Incidence of Amyloid-Related Imaging Abnormalities in Patients With Alzheimer Disease Treated With Anti-β-Amyloid Immunotherapy: A Meta-analysis}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201019},
  pmid    = {36038268},
  url     = {https://doi.org/10.1212/wnl.0000000000201019}
}

@article{andreasen2015-25789616,
  author  = {Andreasen, N. and Simeoni, M. and Ostlund, H. and Lisjo, P. I. and Fladby, T. and Loercher, A. E. and Byrne, G. J. and Murray, F. and others},
  title   = {{First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0098153},
  pmid    = {25789616},
  url     = {https://doi.org/10.1371/journal.pone.0098153}
}

@article{blennow2012-22473769,
  author  = {Blennow, K. and Zetterberg, H. and Rinne, J. O. and Salloway, S. and Wei, J. and Black, R. and Grundman, M. and Liu, E. and others},
  title   = {{Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.90},
  pmid    = {22473769},
  url     = {https://doi.org/10.1001/archneurol.2012.90}
}

@article{edwards2023-37902726,
  author  = {Edwards, A. L. and Collins, J. A. and Junge, C. and Kordasiewicz, H. and Mignon, L. and Wu, S. and Li, Y. and Lin, L. and others},
  title   = {{Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.3861},
  pmid    = {37902726},
  url     = {https://doi.org/10.1001/jamaneurol.2023.3861}
}

@article{lithell2003-12714861,
  author  = {Lithell, H. and Hansson, L. and Skoog, I. and Elmfeldt, D. and Hofman, A. and Olofsson, B. and Trenkwalder, P. and Zanchetti, A. and others},
  title   = {{The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial}},
  journal = {Journal of hypertension},
  year    = {2003},
  doi     = {10.1097/00004872-200305000-00011},
  pmid    = {12714861},
  url     = {https://doi.org/10.1097/00004872-200305000-00011}
}

@article{sharma2026-41985132,
  author  = {Sharma, Mukul and Dong, Qiang and Hirano, Teruyuki and Kasner, Scott Eric and Saver, Jeffrey L. and Masjuan, Jaime and Demchuk, Andrew M. and Cordonnier, Charlotte and others},
  title   = {{Asundexian for Secondary Stroke Prevention}},
  journal = {New England Journal of Medicine},
  year    = {2026},
  doi     = {10.1056/nejmoa2513880},
  pmid    = {41985132},
  url     = {https://doi.org/10.1056/nejmoa2513880}
}

@article{liu2025-40507855,
  author  = {Liu, X. and Baxley, S. and Hebron, M. and Turner, R. S. and Moussa, C.},
  title   = {{Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease}},
  journal = {International journal of molecular sciences},
  year    = {2025},
  doi     = {10.3390/ijms26115044},
  pmid    = {40507855},
  url     = {https://doi.org/10.3390/ijms26115044}
}

@article{wessels2018-29616706,
  author  = {Wessels, A M and Andersen, S W and Dowsett, S A and Siemers, E R},
  title   = {{The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2018},
  doi     = {10.14283/jpad.2018.10},
  pmid    = {29616706},
  url     = {https://doi.org/10.14283/jpad.2018.10}
}

@article{kishnani2009-19606472,
  author  = {Kishnani, P. S. and Sommer, B. R. and Handen, B. L. and Seltzer, B. and Capone, G. T. and Spiridigliozzi, G. A. and Heller, J. H. and Richardson, S. and others},
  title   = {{The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome}},
  journal = {American journal of medical genetics. Part A},
  year    = {2009},
  doi     = {10.1002/ajmg.a.32953},
  pmid    = {19606472},
  url     = {https://doi.org/10.1002/ajmg.a.32953}
}

@article{berry2023-37040116,
  author  = {Berry, D. A. and Dhadda, S. and Kanekiyo, M. and Li, D. and Swanson, C. J. and Irizarry, M. and Kramer, L. D. and Berry, S. M.},
  title   = {{Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2023.7230},
  pmid    = {37040116},
  url     = {https://doi.org/10.1001/jamanetworkopen.2023.7230}
}

@article{humbert2025-40167274,
  author  = {Humbert, Marc and McLaughlin, Vallerie V. and Badesch, David B. and Ghofrani, Hossein Ardeschir and Gibbs, J. Simon R. and Gomberg‐Maitland, Mardi and Preston, Ioana R. and Souza, Rogério and others},
  title   = {{Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death}},
  journal = {New England Journal of Medicine},
  year    = {2025},
  doi     = {10.1056/nejmoa2415160},
  pmid    = {40167274},
  url     = {https://doi.org/10.1056/nejmoa2415160}
}

@article{liu2015-26208959,
  author  = {Liu, E. and Schmidt, M. E. and Margolin, R. and Sperling, R. and Koeppe, R. and Mason, N. S. and Klunk, W. E. and Mathis, C. A. and others},
  title   = {{Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000001877},
  pmid    = {26208959},
  url     = {https://doi.org/10.1212/wnl.0000000000001877}
}

@article{raskind2004-14967774,
  author  = {Raskind, M. A. and Peskind, E. R. and Truyen, L. and Kershaw, P. and Damaraju, C. V.},
  title   = {{The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial}},
  journal = {Archives of neurology},
  year    = {2004},
  doi     = {10.1001/archneur.61.2.252},
  pmid    = {14967774},
  url     = {https://doi.org/10.1001/archneur.61.2.252}
}

@article{rogers2000-10793322,
  author  = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {2000},
  doi     = {10.1016/s0924-977x(00)00067-5},
  pmid    = {10793322},
  url     = {https://doi.org/10.1016/s0924-977x(00)00067-5}
}

@article{li2022-34928310,
  author  = {Li, T. and Li, J. and Yuan, L. and Wu, J. and Jiang, C. and Daniels, J. and Mehta, R. L. and Wang, M. and others},
  title   = {{Effect of Regional vs General Anesthesia on Incidence of Postoperative Delirium in Older Patients Undergoing Hip Fracture Surgery: The RAGA Randomized Trial}},
  journal = {JAMA},
  year    = {2022},
  doi     = {10.1001/jama.2021.22647},
  pmid    = {34928310},
  url     = {https://doi.org/10.1001/jama.2021.22647}
}

@article{hey2024-38902571,
  author  = {Hey, J. A. and Abushakra, S. and Blennow, K. and Reiman, E. M. and Hort, J. and Prins, N. D. and Sheardova, K. and Kesslak, P. and others},
  title   = {{Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease}},
  journal = {Drugs},
  year    = {2024},
  doi     = {10.1007/s40265-024-02067-8},
  pmid    = {38902571},
  url     = {https://doi.org/10.1007/s40265-024-02067-8}
}

@article{ashmawy2025-40232258,
  author  = {Ashmawy, R. E. and Okesanya, O. J. and Ukoaka, B. M. and Daniel, F. M. and Ezedigwe, S. G. and Agboola, A. O. and Ahmed, M. M. and Ogaya, J. B. and others},
  title   = {{Exploring the efficacy and safety of lecanemab in the management of early Alzheimer's disease: A systematic review of clinical evidence}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251331640},
  pmid    = {40232258},
  url     = {https://doi.org/10.1177/13872877251331640}
}

@article{doody2001-11255446,
  author  = {Doody, R. S. and Geldmacher, D. S. and Gordon, B. and Perdomo, C. A. and Pratt, R. D. and {Donepezil Study Group}},
  title   = {{Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.427},
  pmid    = {11255446},
  url     = {https://doi.org/10.1001/archneur.58.3.427}
}

@article{seibyl2016-26823561,
  author  = {Seibyl, J. and Catafau, A. M. and Barthel, H. and Ishii, K. and Rowe, C. C. and Leverenz, J. B. and Ghetti, B. and Ironside, J. W. and others},
  title   = {{Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2016},
  doi     = {10.2967/jnumed.115.161927},
  pmid    = {26823561},
  url     = {https://doi.org/10.2967/jnumed.115.161927}
}

@article{schauer2024-39513754,
  author  = {Schauer, Stephen P and Toth, Balazs and Lee, Julie and Honigberg, Lee A and Ramakrishnan, Vidya and Jiang, Jenny and Kollmorgen, Gwendlyn and Bayfield, Anna and others},
  title   = {{Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.14346},
  pmid    = {39513754},
  url     = {https://doi.org/10.1002/alz.14346}
}

@article{monteiro2023-1c8f9366,
  author  = {Monteiro, C. and Toth, B. and Brunstein, F. and Bobbala, A. and Datta, S. and Ceniceros, R. and Sanabria Bohorquez, S. M. and Anania, V. G. and Wildsmith, K. R. and Schauer, S. P. and Lee, J. and Dolton, M. J. and Ramakrishnan, V. and Abramzon, D. and Teng, E. and {the Lauriet investigators}},
  title   = {{Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207663},
  pmid    = {37643887},
  url     = {https://doi.org/10.1212/wnl.0000000000207663}
}

@article{reisberg2006-16401736,
  author  = {Reisberg, B. and Doody, R. and Stöffler, A. and Schmitt, F. and Ferris, S. and Möbius, H. J.},
  title   = {{A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2006},
  doi     = {10.1001/archneur.63.1.49},
  pmid    = {16401736},
  url     = {https://doi.org/10.1001/archneur.63.1.49}
}

@article{rogers1998-9452942,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {1998},
  doi     = {10.1016/s0924-977x(97)00079-5},
  pmid    = {9452942},
  url     = {https://doi.org/10.1016/s0924-977x(97)00079-5}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{fleisher2026-42441396,
  author  = {Fleisher, Adam S and Munsie, Leanne and Mancini, Michele and Cheng, Yun-Ju and Guo, Jiaying and Nuthall, Hugh and Otero, Diana Svaldi and Kotari, Vikas and others},
  title   = {{Ceperognastat in Early Symptomatic Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2026},
  doi     = {10.1001/jama.2026.12768},
  pmid    = {42441396},
  url     = {https://doi.org/10.1001/jama.2026.12768}
}

@article{rosenheck2007-17984395,
  author  = {Rosenheck, R. A. and Leslie, D. L. and Sindelar, J. L. and Miller, E. A. and Tariot, P. N. and Dagerman, K. S. and Davis, S. M. and Lebowitz, B. D. and others},
  title   = {{Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease}},
  journal = {Archives of general psychiatry},
  year    = {2007},
  doi     = {10.1001/archpsyc.64.11.1259},
  pmid    = {17984395},
  url     = {https://doi.org/10.1001/archpsyc.64.11.1259}
}

@article{aisen2006-17082468,
  author  = {Aisen, P. S. and Saumier, D. and Briand, R. and Laurin, J. and Gervais, F. and Tremblay, P. and Garceau, D.},
  title   = {{A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2006},
  doi     = {10.1212/01.wnl.0000244346.08950.64},
  pmid    = {17082468},
  url     = {https://doi.org/10.1212/01.wnl.0000244346.08950.64}
}

@article{harrington2011-21592048,
  author  = {Harrington, C. and Sawchak, S. and Chiang, C. and Davies, J. and Donovan, C. and Saunders, A. M. and Irizarry, M. and Jeter, B. and others},
  title   = {{Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies}},
  journal = {Current Alzheimer research},
  year    = {2011},
  doi     = {10.2174/156720511796391935},
  pmid    = {21592048},
  url     = {https://doi.org/10.2174/156720511796391935}
}

@article{mathioudakis2025-41144242,
  author  = {Mathioudakis, Nestoras Nicolas and Lalani, Benjamin and Abusamaan, Mohammed S. and Alderfer, Mary Ellen and Alver, Defne and Dobs, Adrian and Kane, Brian and others},
  title   = {{An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program}},
  journal = {JAMA},
  year    = {2025},
  doi     = {10.1001/jama.2025.19563},
  pmid    = {41144242},
  url     = {https://doi.org/10.1001/jama.2025.19563}
}

@article{farlow2000-11096224,
  author  = {Farlow, M. and Anand, R. and Messina, J. and Hartman, R. and Veach, J.},
  title   = {{A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease}},
  journal = {European neurology},
  year    = {2000},
  doi     = {10.1159/000008243},
  pmid    = {11096224},
  url     = {https://doi.org/10.1159/000008243}
}

@article{vandyck2025-41355080,
  author  = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.},
  title   = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70905},
  pmid    = {41355080},
  url     = {https://doi.org/10.1002/alz.70905}
}

@article{atri2026-42128444,
  author  = {Atri, A. and Apostolova, L. G. and Iwata, A. and Wessels, A. M. and Atkins, A. and Lu, M. and Ye, W. and Ryan, S. and Doty, E. G.},
  title   = {{Clinical Meaningfulness of Donanemab in Early Symptomatic Alzheimer Disease: Data From the Randomized Phase 3 TRAILBLAZER-ALZ 2 Trial}},
  journal = {Neurology: Clinical Practice},
  year    = {2026},
  doi     = {10.1212/CPJ.0000000000200621},
  pmid    = {42128444},
  url     = {https://doi.org/10.1212/CPJ.0000000000200621}
}

@article{davidson2026-41109840,
  author  = {Davidson, M. H. and Szarek, M. and Scheltens, P. and Vijverberg, E. and Hsieh, A. and Ditmarsch, M. and Kling, D. and Curcio, D. and others},
  title   = {{Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2025.100394},
  pmid    = {41109840},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100394}
}

@article{johnson2013-23375563,
  author  = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others},
  title   = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.10.007},
  pmid    = {23375563},
  url     = {https://doi.org/10.1016/j.jalz.2012.10.007}
}

@article{skoog2005-16109319,
  author  = {Skoog, I. and Lithell, H. and Hansson, L. and Elmfeldt, D. and Hofman, A. and Olofsson, B. and Trenkwalder, P. and Zanchetti, A. and others},
  title   = {{Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)}},
  journal = {American journal of hypertension},
  year    = {2005},
  doi     = {10.1016/j.amjhyper.2005.02.013},
  pmid    = {16109319},
  url     = {https://doi.org/10.1016/j.amjhyper.2005.02.013}
}

@article{sperling2012-22305802,
  author  = {Sperling, R. and Salloway, S. and Brooks, D. J. and Tampieri, D. and Barakos, J. and Fox, N. C. and Raskind, M. and Sabbagh, M. and others},
  title   = {{Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis}},
  journal = {The Lancet. Neurology},
  year    = {2012},
  doi     = {10.1016/s1474-4422(12)70015-7},
  pmid    = {22305802},
  url     = {https://doi.org/10.1016/s1474-4422(12)70015-7}
}

@article{farlow2001-11255445,
  author  = {Farlow, M. R. and Hake, A. and Messina, J. and Hartman, R. and Veach, J. and Anand, R.},
  title   = {{Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.417},
  pmid    = {11255445},
  url     = {https://doi.org/10.1001/archneur.58.3.417}
}

@article{cheng2014-23582750,
  author  = {Cheng, S. T. and Chow, P. K. and Song, Y. Q. and Yu, E. C. and Chan, A. C. and Lee, T. M. and Lam, J. H.},
  title   = {{Mental and physical activities delay cognitive decline in older persons with dementia}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2014},
  doi     = {10.1016/j.jagp.2013.01.060},
  pmid    = {23582750},
  url     = {https://doi.org/10.1016/j.jagp.2013.01.060}
}

@article{guthrie2020-32568196,
  author  = {Guthrie, H. and Honig, L. S. and Lin, H. and Sink, K. M. and Blondeau, K. and Quartino, A. and Dolton, M. and Carrasco-Triguero, M. and others},
  title   = {{Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2020},
  doi     = {10.3233/jad-200134},
  pmid    = {32568196},
  url     = {https://doi.org/10.3233/jad-200134}
}

@article{carlson2016-27239538,
  author  = {Carlson, C. and Siemers, E. and Hake, A. and Case, M. and Hayduk, R. and Suhy, J. and Oh, J. and Barakos, J.},
  title   = {{Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)},
  year    = {2016},
  doi     = {10.1016/j.dadm.2016.02.004},
  pmid    = {27239538},
  url     = {https://doi.org/10.1016/j.dadm.2016.02.004}
}

@article{baddeley2015-25320049,
  author  = {Baddeley, T. C. and McCaffrey, J. and Storey, J. M. and Cheung, J. K. and Melis, V. and Horsley, D. and Harrington, C. R. and Wischik, C. M.},
  title   = {{Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease}},
  journal = {The Journal of pharmacology and experimental therapeutics},
  year    = {2015},
  doi     = {10.1124/jpet.114.219352},
  pmid    = {25320049},
  url     = {https://doi.org/10.1124/jpet.114.219352}
}

@article{salloway2023-7521651f,
  author  = {Salloway, Stephen and Lee, Elly and Papka, Michelle and Pain, Andrew and Oru, Ena and Ferguson, Margaret B. and Wang, Hong and Case, Michael G. and others},
  title   = {{TRAILBLAZER-ALZ 4: Topline Study Results Directly Comparing Donanemab to Aducanumab on Amyloid Lowering in Early, Symptomatic Alzheimer's Disease}},
  journal = {BJPsych Open},
  year    = {2023},
  doi     = {10.1192/bjo.2023.227},
  url     = {https://doi.org/10.1192/bjo.2023.227}
}

@article{nakamura2024-39369280,
  author  = {Nakamura, Y. and Adachi, J. and Hirota, N. and Iba, K. and Shimizu, K. and Nakai, M. and Takahashi, K. and Mori, N.},
  title   = {{Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2024},
  doi     = {10.1002/alz.14282},
  pmid    = {39369280},
  url     = {https://doi.org/10.1002/alz.14282}
}

@article{rosenberg2025-41350162,
  author  = {Rosenberg, P. B. and Amjad, H. and Burhanullah, H. and Nowrangi, M. and Vandrey, R. and Pierre, M. J. and Outen, J. D. and Schultz, M. and Marano, C. and Agronin, M. and others},
  title   = {{A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease}},
  journal = {The American Journal of Geriatric Psychiatry},
  year    = {2025},
  doi     = {10.1016/j.jagp.2025.10.011},
  pmid    = {41350162},
  url     = {https://doi.org/10.1016/j.jagp.2025.10.011}
}

@article{wischik2026-41570392,
  author  = {Wischik, C. M. and Stefanacci, R. and Bentham, P. and Gauthier, S. and Zetterberg, H. and Wilcock, G. K. and Froelich, L. and Burns, A. and MacSweeney, E. and Ballard, C. and others},
  title   = {{Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100480},
  pmid    = {41570392},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100480}
}

@article{yassine2026-42315445,
  author  = {Yassine, Hussein N and Pour, Sara Ghasem and Juarez, Marlene and Arrelanas, Isabella C and Ali, Nada and Dikeman, Dante and Sanchez, Ashley and Park, Jackson and others},
  title   = {{CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial}},
  journal = {EBioMedicine},
  year    = {2026},
  doi     = {10.1016/j.ebiom.2026.106316},
  pmid    = {42315445},
  url     = {https://doi.org/10.1016/j.ebiom.2026.106316}
}

@article{kessler2008-18972062,
  author  = {Kessler, H. and Pajonk, F. G. and Bach, D. and Schneider-Axmann, T. and Falkai, P. and Herrmann, W. and Multhaup, G. and Wiltfang, J. and others},
  title   = {{Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial}},
  journal = {Journal of neural transmission (Vienna, Austria : 1996)},
  year    = {2008},
  doi     = {10.1007/s00702-008-0136-2},
  pmid    = {18972062},
  url     = {https://doi.org/10.1007/s00702-008-0136-2}
}

@article{ossenkoppele2022-35643092,
  author  = {Ossenkoppele, R. and van der Kant, R. and Hansson, O.},
  title   = {{Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(22)00168-5},
  pmid    = {35643092},
  url     = {https://doi.org/10.1016/s1474-4422(22)00168-5}
}

@article{liuseifert2015-26402769,
  author  = {Liu-Seifert, H. and Siemers, E. and Price, K. and Han, B. and Selzler, K. J. and Henley, D. and Sundell, K. and Aisen, P. and others},
  title   = {{Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142508},
  pmid    = {26402769},
  url     = {https://doi.org/10.3233/jad-142508}
}

@article{mohamed2012-21939611,
  author  = {Mohamed, S. and Rosenheck, R. and Lyketsos, C. G. and Kaczynski, R. and Sultzer, D. L. and Schneider, L. S.},
  title   = {{Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease}},
  journal = {The Journal of clinical psychiatry},
  year    = {2012},
  doi     = {10.4088/jcp.10m06574},
  pmid    = {21939611},
  url     = {https://doi.org/10.4088/jcp.10m06574}
}

@article{wang2019-31488882,
  author  = {Wang, X. and Sun, G. and Feng, T. and Zhang, J. and Huang, X. and Wang, T. and Xie, Z. and Chu, X. and others},
  title   = {{Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression}},
  journal = {Cell research},
  year    = {2019},
  doi     = {10.1038/s41422-019-0216-x},
  pmid    = {31488882},
  url     = {https://doi.org/10.1038/s41422-019-0216-x}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{loomis2024-38165296,
  author  = {Loomis, S. J. and Miller, R. and Castrillo-Viguera, C. and Umans, K. and Cheng, W. and O'Gorman, J. and Hughes, R. and Budd Haeberlein, S. and others},
  title   = {{Genome-Wide Association Studies of ARIA From the Aducanumab Phase 3 ENGAGE and EMERGE Studies}},
  journal = {Neurology},
  year    = {2024},
  doi     = {10.1212/wnl.0000000000207919},
  pmid    = {38165296},
  url     = {https://doi.org/10.1212/wnl.0000000000207919}
}

@article{thal2002-12084879,
  author  = {Thal, Dietmar Rudolf and Rüb, Udo and Orantes, Mario and Braak, Heiko},
  title   = {{Phases of Aβ-deposition in the human brain and its relevance for the development of AD}},
  journal = {Neurology},
  year    = {2002},
  doi     = {10.1212/wnl.58.12.1791},
  pmid    = {12084879},
  url     = {https://doi.org/10.1212/wnl.58.12.1791}
}

@article{turner2020-32468646,
  author  = {Turner, R. S. and Hebron, M. L. and Lawler, A. and Mundel, E. E. and Yusuf, N. and Starr, J. N. and Anjum, M. and Pagan, F. and others},
  title   = {{Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease}},
  journal = {Annals of neurology},
  year    = {2020},
  doi     = {10.1002/ana.25775},
  pmid    = {32468646},
  url     = {https://doi.org/10.1002/ana.25775}
}

@article{farlow2015-25918556,
  author  = {Farlow, M. R. and Andreasen, N. and Riviere, M. E. and Vostiar, I. and Vitaliti, A. and Sovago, J. and Caputo, A. and Winblad, B. and others},
  title   = {{Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0108-3},
  pmid    = {25918556},
  url     = {https://doi.org/10.1186/s13195-015-0108-3}
}

@article{shaw2006-16549835,
  author  = {Shaw, E. G. and Rosdhal, R. and D'Agostino, R. B. and Lovato, J. and Naughton, M. J. and Robbins, M. E. and Rapp, SR.},
  title   = {{Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life}},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year    = {2006},
  doi     = {10.1200/jco.2005.03.3001},
  pmid    = {16549835},
  url     = {https://doi.org/10.1200/jco.2005.03.3001}
}

@article{black2010-20505438,
  author  = {Black, R. S. and Sperling, R. A. and Safirstein, B. and Motter, R. N. and Pallay, A. and Nichols, A. and Grundman, M.},
  title   = {{A single ascending dose study of bapineuzumab in patients with Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2010},
  doi     = {10.1097/wad.0b013e3181c53b00},
  pmid    = {20505438},
  url     = {https://doi.org/10.1097/wad.0b013e3181c53b00}
}

@article{silveira2025-40587145,
  author  = {Silveira, C. R. A. and Coleman, K. K. L. and Borron, K. and Tirona, R. G. and Rupar, C. A. and Zou, G. and Hegele, R. A. and Wellington, C. and others},
  title   = {{Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.1687},
  pmid    = {40587145},
  url     = {https://doi.org/10.1001/jamaneurol.2025.1687}
}

@article{sabbagh2023-37695107,
  author  = {Sabbagh, M. N. and Mathew, P. and Blau, A.},
  title   = {{A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2023},
  doi     = {10.1097/wad.0000000000000578},
  pmid    = {37695107},
  url     = {https://doi.org/10.1097/wad.0000000000000578}
}

@article{chen2025-40189473,
  author  = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others},
  title   = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100160},
  pmid    = {40189473},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100160}
}

@article{portron2020-31883703,
  author  = {Portron, A. and Jordan, P. and Draper, K. and Muenzer, C. and Dickerson, D. and van Iersel, T. and Hofmann, C.},
  title   = {{A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers}},
  journal = {Clinical therapeutics},
  year    = {2020},
  doi     = {10.1016/j.clinthera.2019.11.015},
  pmid    = {31883703},
  url     = {https://doi.org/10.1016/j.clinthera.2019.11.015}
}

@article{dicaro2026-41943055,
  author  = {Di Caro, V. and Cho, E. and Thiel, J. and Lizama, B. N. and Koel-Simmelink, M. J. A. and Pandey, K. and Duong, D. and Seyfried, N. T. and others},
  title   = {{Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2026},
  doi     = {10.1186/s13195-026-02025-4},
  pmid    = {41943055},
  url     = {https://doi.org/10.1186/s13195-026-02025-4}
}

@article{ringman2012-23107780,
  author  = {Ringman, J. M. and Frautschy, S. A. and Teng, E. and Begum, A. N. and Bardens, J. and Beigi, M. and Gylys, K. H. and Badmaev, V. and others},
  title   = {{Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2012},
  doi     = {10.1186/alzrt146},
  pmid    = {23107780},
  url     = {https://doi.org/10.1186/alzrt146}
}

@article{may2015-25609634,
  author  = {May, P. C. and Willis, B. A. and Lowe, S. L. and Dean, R. A. and Monk, S. A. and Cocke, P. J. and Audia, J. E. and Boggs, L. N. and others},
  title   = {{The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {2015},
  doi     = {10.1523/jneurosci.4129-14.2015},
  pmid    = {25609634},
  url     = {https://doi.org/10.1523/jneurosci.4129-14.2015}
}

@article{cummings2022-35516416,
  author  = {Cummings, J. and Lee, G. and Nahed, P. and Kambar, M. E. Z. N. and Zhong, K. and Fonseca, J. and Taghva, K.},
  title   = {{Alzheimer's disease drug development pipeline: 2022}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2022},
  doi     = {10.1002/trc2.12295},
  pmid    = {35516416},
  url     = {https://doi.org/10.1002/trc2.12295}
}

@article{wong2010-20501908,
  author  = {Wong, D. F. and Rosenberg, P. B. and Zhou, Y. and Kumar, A. and Raymont, V. and Ravert, H. T. and Dannals, R. F. and Nandi, A. and others},
  title   = {{In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2010},
  doi     = {10.2967/jnumed.109.069088},
  pmid    = {20501908},
  url     = {https://doi.org/10.2967/jnumed.109.069088}
}

@article{haroon2024-39058809,
  author  = {Haroon, J. and Jordan, K. and Mahdavi, K. and Rindner, E. and Becerra, S. and Surya, JR. and Zielinski, M. and Venkatraman, V. and others},
  title   = {{A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias}},
  journal = {Medicine},
  year    = {2024},
  doi     = {10.1097/md.0000000000039027},
  pmid    = {39058809},
  url     = {https://doi.org/10.1097/md.0000000000039027}
}

@article{aumont2025-40880087,
  author  = {Aumont, E. and Therriault, J. and Kwan, A. T. H. and Carello-Collar, G. and Arfaie, S. and Hall, B. J. and Ferrari-Souza, J. P. and Woo, M. S. and others},
  title   = {{The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease}},
  journal = {JAMA network open},
  year    = {2025},
  doi     = {10.1001/jamanetworkopen.2025.29665},
  pmid    = {40880087},
  url     = {https://doi.org/10.1001/jamanetworkopen.2025.29665}
}

@article{jain2025-41213043,
  author  = {Jain, Sneha S. and Sun, Tony and Pierson, Emma and Oliver, Francisco Roedan and Malta, Paloma P and Castillo, Michelle and Wan, Ningxin and Alishetti, Shudhanshu and others},
  title   = {{Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence}},
  journal = {JAMA Cardiology},
  year    = {2025},
  doi     = {10.1001/jamacardio.2025.4591},
  pmid    = {41213043},
  url     = {https://doi.org/10.1001/jamacardio.2025.4591}
}

@article{wang2020-32920628,
  author  = {Wang, H. Y. and Pei, Z. and Lee, K. C. and Lopez-Brignoni, E. and Nikolov, B. and Crowley, C. A. and Marsman, M. R. and Barbier, R. and others},
  title   = {{PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2020},
  doi     = {10.14283/jpad.2020.6},
  pmid    = {32920628},
  url     = {https://doi.org/10.14283/jpad.2020.6}
}

@article{gonzales2023-37679434,
  author  = {Gonzales, M. M. and Garbarino, V. R. and Kautz, T. F. and Palavicini, J. P. and Lopez-Cruzan, M. and Dehkordi, S. K. and Mathews, J. J. and Zare, H. and others},
  title   = {{Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial}},
  journal = {Nature medicine},
  year    = {2023},
  doi     = {10.1038/s41591-023-02543-w},
  pmid    = {37679434},
  url     = {https://doi.org/10.1038/s41591-023-02543-w}
}

@article{aldea2022-35676943,
  author  = {Aldea, R. and Grimm, H. P. and Gieschke, R. and Hofmann, C. and Lott, D. and Bullain, S. and Delmar, P. and Klein, G. and others},
  title   = {{In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic model}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2022},
  doi     = {10.1002/trc2.12306},
  pmid    = {35676943},
  url     = {https://doi.org/10.1002/trc2.12306}
}

@article{cummings2024-38659717,
  author  = {Cummings, J. and Zhou, Y. and Lee, G. and Zhong, K. and Fonseca, J. and Cheng, F.},
  title   = {{Alzheimer's disease drug development pipeline: 2024}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2024},
  doi     = {10.1002/trc2.12465},
  pmid    = {38659717},
  url     = {https://doi.org/10.1002/trc2.12465}
}

@article{cummings2014-a7c335d7,
  author  = {Cummings, Jeffrey L. and Cho, William and Ward, Michael Emmerson and Friesenhahn, Michel J. and Brunstein, Flávia and Honigberg, Lee A. and Clayton, David and Mortensen, Deborah L. and others},
  title   = {{O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE}},
  journal = {Alzheimer s \& Dementia},
  year    = {2014},
  doi     = {10.1016/j.jalz.2014.04.450},
  url     = {https://doi.org/10.1016/j.jalz.2014.04.450}
}

@article{lasser2015-f0473682,
  author  = {Lasser, Robert A. and Ostrowitzki, Susanne and Scheltens, Philip and Boada, Merçé and Dubois, Bruno and Dorflinger, Ernest E. and Balas, Bogdan and Nikolcheva, Tania and others},
  title   = {{DT‐01‐03: Efficacy and safety of gantenerumab in prodromal Alzheimer's disease: Results from scarlet road—a global, multicenter trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2015},
  doi     = {10.1016/j.jalz.2015.08.153},
  url     = {https://doi.org/10.1016/j.jalz.2015.08.153}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{ross2022-35344024,
  author  = {Ross, E. L. and Weinberg, M. S. and Arnold, S. E.},
  title   = {{Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.0315},
  pmid    = {35344024},
  url     = {https://doi.org/10.1001/jamaneurol.2022.0315}
}

@article{bayer2005-15642910,
  author  = {Bayer, A. J. and Bullock, R. and Jones, R. W. and Wilkinson, D. and Paterson, K. R. and Jenkins, L. and Millais, S. B. and Donoghue, S.},
  title   = {{Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD}},
  journal = {Neurology},
  year    = {2005},
  doi     = {10.1212/01.wnl.0000148604.77591.67},
  pmid    = {15642910},
  url     = {https://doi.org/10.1212/01.wnl.0000148604.77591.67}
}

@article{ramakrishnan2024-39350369,
  author  = {Ramakrishnan, V and Bender, B and Langenhorst, J and Magnusson, M O and Dolton, M and Shim, J and Fuji, R N and Monteiro, C and others},
  title   = {{Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2024},
  doi     = {10.14283/jpad.2024.146},
  pmid    = {39350369},
  url     = {https://doi.org/10.14283/jpad.2024.146}
}

@article{wolters2024-38380503,
  author  = {Wolters, Frank J and Labrecque, Jeremy A},
  title   = {{Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.13690},
  pmid    = {38380503},
  url     = {https://doi.org/10.1002/alz.13690}
}

@article{schneider2019-31282954,
  author  = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others},
  title   = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1868},
  pmid    = {31282954},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1868}
}

@article{liang2014-25294055,
  author  = {Liang, J. and Li, F. and Wei, C. and Song, H. and Wu, L. and Tang, Y. and Jia, J.},
  title   = {{Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia}},
  journal = {Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association},
  year    = {2014},
  doi     = {10.1016/j.jstrokecerebrovasdis.2014.06.005},
  pmid    = {25294055},
  url     = {https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.06.005}
}

@article{cummings2023-37251912,
  author  = {Cummings, J. and Zhou, Y. and Lee, G. and Zhong, K. and Fonseca, J. and Cheng, F.},
  title   = {{Alzheimer's disease drug development pipeline: 2023}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12385},
  pmid    = {37251912},
  url     = {https://doi.org/10.1002/trc2.12385}
}

@article{yan2025-40242445,
  author  = {Yan, L. and Zhang, L. and Xu, Z. and Luo, Z.},
  title   = {{A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for lecanemab}},
  journal = {Frontiers in pharmacology},
  year    = {2025},
  doi     = {10.3389/fphar.2025.1559447},
  pmid    = {40242445},
  url     = {https://doi.org/10.3389/fphar.2025.1559447}
}

@article{thal2015-26141264,
  author  = {Thal, D. R. and Beach, T. G. and Zanette, M. and Heurling, K. and Chakrabarty, A. and Ismail, A. and Smith, A. P. and Buckley, C.},
  title   = {{[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2015.05.018},
  pmid    = {26141264},
  url     = {https://doi.org/10.1016/j.jalz.2015.05.018}
}

@article{mcgeer2013-24052108,
  author  = {McGeer, P. L. and McGeer, E. G.},
  title   = {{The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy}},
  journal = {Acta neuropathologica},
  year    = {2013},
  doi     = {10.1007/s00401-013-1177-7},
  pmid    = {24052108},
  url     = {https://doi.org/10.1007/s00401-013-1177-7}
}

@article{bullich2022-35897078,
  author  = {Bullich, Santiago and Mueller, Andre and De Santi, Susan and Koglin, Norman and Krause, Stephen and Kaplow, June and Kanekiyo, Michio and Roé-Vellvé, Núria and others},
  title   = {{Evaluation of tau deposition using 18F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-01048-x},
  pmid    = {35897078},
  url     = {https://doi.org/10.1186/s13195-022-01048-x}
}

@article{blaettler2016-916a25c5,
  author  = {Blaettler, Thomas and Smith, Janice and Smith, Jillian P. and Paul, Robert H. and Asnaghi, Veronica and Fuji, Reina N. and Quartino, Angelica Linnea and Honigberg, Lee A. and others},
  title   = {{P2‐003: Clinical Trial Design of Cread: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Phase 3 Study to Evaluate Crenezumab Treatment in Patients with Prodromal‐To‐Mild Alzheimer’s Disease}},
  journal = {Alzheimer s \& Dementia},
  year    = {2016},
  doi     = {10.1016/j.jalz.2016.06.1207},
  url     = {https://doi.org/10.1016/j.jalz.2016.06.1207}
}

@article{lombardo2015-d54d3985,
  author  = {Lombardo, Ilise and Ramaswamy, Geetha and Piscitelli, Stephen C. and Friedhoff, Lawrence T.},
  title   = {{DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study}},
  journal = {Alzheimer s \& Dementia},
  year    = {2015},
  doi     = {10.1016/j.jalz.2015.08.154},
  url     = {https://doi.org/10.1016/j.jalz.2015.08.154}
}

@article{watkins1994-8139084,
  author  = {Watkins, Paul Brent},
  title   = {{Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease}},
  journal = {JAMA},
  year    = {1994},
  doi     = {10.1001/jama.1994.03510370044030},
  pmid    = {8139084},
  url     = {https://doi.org/10.1001/jama.1994.03510370044030}
}

@article{mori2015-88c17657,
  author  = {Mori, Etsuro and Ikeda, Manabu and Nagai, Reiko and Matsuo, Kazutaka and Nakagawa, Masaki and Kosaka, Kenji},
  title   = {{Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial}},
  journal = {Alzheimer's Research \& Therapy},
  year    = {2015},
  doi     = {10.1186/s13195-014-0081-2},
  url     = {https://doi.org/10.1186/s13195-014-0081-2}
}

@article{timko2026-41931297,
  author  = {Timko, Noah J. and Wright, Mary Cooter and Reese, Melody A. and Boykin, Piper C. and Emerson, Jacqueline M. and Woldorff, Marty G. and Eleswarpu, Sarada and Herbert, J. Taylor and others},
  title   = {{Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients}},
  journal = {JAMA Network Open},
  year    = {2026},
  doi     = {10.1001/jamanetworkopen.2026.2289},
  pmid    = {41931297},
  url     = {https://doi.org/10.1001/jamanetworkopen.2026.2289}
}

@article{assogna2025-40046339,
  author  = {Assogna, Martina and Di Lorenzo, Francesco and Bonnı̀, Sonia and Borghi, Ilaria and Irelli, Emanuele Cerulli and Mencarelli, Lucia and Maiella, Michele and Minei, Marilena and others},
  title   = {{Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients}},
  journal = {Brain Communications},
  year    = {2025},
  doi     = {10.1093/braincomms/fcaf080},
  pmid    = {40046339},
  url     = {https://doi.org/10.1093/braincomms/fcaf080}
}

@article{betz2021-34550082,
  author  = {Betz, M. E. and Polzer, E. and Nearing, K. and Knoepke, C. E. and Johnson, R. L. and Meador, L. and Matlock, D. D.},
  title   = {{Feasibility and Acceptability of a Web-Based Caregiver Decision Aid (Safety in Dementia) for Firearm Access: Pilot Randomized Controlled Trial}},
  journal = {JMIR formative research},
  year    = {2021},
  doi     = {10.2196/30990},
  pmid    = {34550082},
  url     = {https://doi.org/10.2196/30990}
}

@article{smith2012-22566505,
  author  = {Smith, G. S. and Laxton, A. W. and Tang-Wai, D. F. and McAndrews, M. P. and Diaconescu, A. O. and Workman, C. I. and Lozano, A. M.},
  title   = {{Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2012.590},
  pmid    = {22566505},
  url     = {https://doi.org/10.1001/archneurol.2012.590}
}

@article{valentisoler2015-26388764,
  author  = {Valentí Soler, M. and Agüera-Ortiz, L. and Olazarán Rodríguez, J. and Mendoza Rebolledo, C. and Pérez Muñoz, A. and Rodríguez Pérez, I. and Osa Ruiz, E. and Barrios Sánchez, A. and others},
  title   = {{Social robots in advanced dementia}},
  journal = {Frontiers in aging neuroscience},
  year    = {2015},
  doi     = {10.3389/fnagi.2015.00133},
  pmid    = {26388764},
  url     = {https://doi.org/10.3389/fnagi.2015.00133}
}

@article{hager2007-17982894,
  author  = {Hager, K. and Kenklies, M. and McAfoose, J. and Engel, J. and Münch, G.},
  title   = {{Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis}},
  journal = {Journal of neural transmission. Supplementum},
  year    = {2007},
  doi     = {10.1007/978-3-211-73574-9_24},
  pmid    = {17982894},
  url     = {https://doi.org/10.1007/978-3-211-73574-9_24}
}

@article{rafii2023-35971310,
  author  = {Rafii, M. S. and Sperling, R. A. and Donohue, M. C. and Zhou, J. and Roberts, C. and Irizarry, M. C. and Dhadda, S. and Sethuraman, G. and others},
  title   = {{The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12748},
  pmid    = {35971310},
  url     = {https://doi.org/10.1002/alz.12748}
}

@article{arrighi2016-25669746,
  author  = {Arrighi, H. M. and Barakos, J. and Barkhof, F. and Tampieri, D. and Jack, C. and Melançon, D. and Morris, K. and Ketter, N. and others},
  title   = {{Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis}},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  year    = {2016},
  doi     = {10.1136/jnnp-2014-309493},
  pmid    = {25669746},
  url     = {https://doi.org/10.1136/jnnp-2014-309493}
}

@article{debattista2024-38993656,
  author  = {DeBattista, C. and Schatzberg, A. F.},
  title   = {{The Black Book of Psychotropic Dosing and Monitoring}},
  journal = {Psychopharmacology bulletin},
  year    = {2024},
  doi     = {10.64719/pb.4493},
  pmid    = {38993656},
  url     = {https://doi.org/10.64719/pb.4493}
}

@article{cummings2021-34095440,
  author  = {Cummings, J. and Lee, G. and Zhong, K. and Fonseca, J. and Taghva, K.},
  title   = {{Alzheimer's disease drug development pipeline: 2021}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2021},
  doi     = {10.1002/trc2.12179},
  pmid    = {34095440},
  url     = {https://doi.org/10.1002/trc2.12179}
}

@article{alosco2025-39994806,
  author  = {Alosco, Michael L and Pérez, Jhony Mejía and Culhane, Julia E and Shankar, Ranjani and Nowinski, Christopher J and Bureau, Samantha and Mundada, Nidhi and Smith, Karen and others},
  title   = {{18F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy}},
  journal = {Molecular neurodegeneration},
  year    = {2025},
  doi     = {10.1186/s13024-025-00808-1},
  pmid    = {39994806},
  url     = {https://doi.org/10.1186/s13024-025-00808-1}
}

@article{haeberlein2018-12a02583,
  author  = {Haeberlein, Samantha Budd and Gheuens, Sarah and Chen, Tianle and O'Gorman, John T. and von Rosenstiel, Philipp and Chiao, Ping and Wang, Guanfang and von Hehn, Christian and others},
  title   = {{Aducanumab 36-month data from PRIME: a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.004)}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.90.15_supplement.s2.004},
  url     = {https://doi.org/10.1212/wnl.90.15_supplement.s2.004}
}

@article{bae2024-39113808,
  author  = {Bae, S. and Liu, K. and Pouliopoulos, A. N. and Ji, R. and Jiménez-Gambín, S. and Yousefian, O. and Kline-Schoder, A. R. and Batts, A. J. and others},
  title   = {{Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping}},
  journal = {Theranostics},
  year    = {2024},
  doi     = {10.7150/thno.94206},
  pmid    = {39113808},
  url     = {https://doi.org/10.7150/thno.94206}
}

@article{torresyaghi2025-41286676,
  author  = {Torres-Yaghi, Y. and Chrones, L. and Abler, V. and Brunson, G.},
  title   = {{Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study}},
  journal = {BMC Neurology},
  year    = {2025},
  doi     = {10.1186/s12883-025-04496-8},
  pmid    = {41286676},
  url     = {https://doi.org/10.1186/s12883-025-04496-8}
}

@article{kim2022-35260170,
  author  = {Kim, J. and Yon, D. K. and Choi, K. Y. and Lee, J. J. and Kim, N. and Lee, K. H. and Kim, J. G.},
  title   = {{Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-00978-w},
  pmid    = {35260170},
  url     = {https://doi.org/10.1186/s13195-022-00978-w}
}

@article{maczurek2008-18655815,
  author  = {Maczurek, A. and Hager, K. and Kenklies, M. and Sharman, M. and Martins, R. and Engel, J. and Carlson, D. A. and Münch, G.},
  title   = {{Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease}},
  journal = {Advanced drug delivery reviews},
  year    = {2008},
  doi     = {10.1016/j.addr.2008.04.015},
  pmid    = {18655815},
  url     = {https://doi.org/10.1016/j.addr.2008.04.015}
}

@article{pagan2025-40565990,
  author  = {Pagán, Fernando and Torres-Yaghi, Yasar A. and Hebron, Michaeline L. and Wilmarth, Barbara and Turner, Raymond Scott and Matar, Sara and Liu, Xiaoguang and Ferrante, Dalila and others},
  title   = {{Safety, Cognitive, and Behavioral Outcomes in Patients with Dementia with Lewy Bodies Treated with Nilotinib}},
  journal = {Journal of Clinical Medicine},
  year    = {2025},
  doi     = {10.3390/jcm14124245},
  pmid    = {40565990},
  url     = {https://doi.org/10.3390/jcm14124245}
}

@article{klein2019-31831056,
  author  = {Klein, G. and Delmar, P. and Voyle, N. and Rehal, S. and Hofmann, C. and Abi-Saab, D. and Andjelkovic, M. and Ristic, S. and others},
  title   = {{Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0559-z},
  pmid    = {31831056},
  url     = {https://doi.org/10.1186/s13195-019-0559-z}
}

@article{viglietta2016-5b6a5200,
  author  = {Viglietta, Vissia and O'Gorman, John T. and Williams, Leslie J. and Tian, Ying and Sandrock, Alfred W. and Doody, Rachelle Smith and Salloway, Stephen and Barkhof, Frederik and others},
  title   = {{Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003)}},
  journal = {Neurology},
  year    = {2016},
  doi     = {10.1212/wnl.86.16_supplement.s1.003},
  url     = {https://doi.org/10.1212/wnl.86.16_supplement.s1.003}
}

@article{sultzer2008-18519523,
  author  = {Sultzer, David L. and Thomas, Sonia and Tariot, Pierre N. and Dagerman, Karen and Lebowitz, Barry D. and Lyketsos, Constantine George and Rosenheck, Robert Alan and Hsiao, John and others},
  title   = {{Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial}},
  journal = {American Journal of Psychiatry},
  year    = {2008},
  doi     = {10.1176/appi.ajp.2008.07111779},
  pmid    = {18519523},
  url     = {https://doi.org/10.1176/appi.ajp.2008.07111779}
}

@article{eyjolfsdottir2016-27389402,
  author  = {Eyjolfsdottir, H. and Eriksdotter, M. and Linderoth, B. and Lind, G. and Juliusson, B. and Kusk, P. and Almkvist, O. and Andreasen, N. and others},
  title   = {{Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0195-9},
  pmid    = {27389402},
  url     = {https://doi.org/10.1186/s13195-016-0195-9}
}

@article{dickerson2013-24130528,
  author  = {Dickerson, B. C. and Wolk, D. A. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau}},
  journal = {Frontiers in aging neuroscience},
  year    = {2013},
  doi     = {10.3389/fnagi.2013.00055},
  pmid    = {24130528},
  url     = {https://doi.org/10.3389/fnagi.2013.00055}
}

@article{vitek2023-36749830,
  author  = {Vitek, G. E. and Decourt, B. and Sabbagh, M. N.},
  title   = {{Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease}},
  journal = {Expert opinion on investigational drugs},
  year    = {2023},
  doi     = {10.1080/13543784.2023.2178414},
  pmid    = {36749830},
  url     = {https://doi.org/10.1080/13543784.2023.2178414}
}

@article{cupido2022-35921096,
  author  = {Cupido, A. J. and Reeskamp, L. F. and Hingorani, A. D. and Finan, C. and Asselbergs, F. W. and Hovingh, G. K. and Schmidt, A. F.},
  title   = {{Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study}},
  journal = {JAMA cardiology},
  year    = {2022},
  doi     = {10.1001/jamacardio.2022.2333},
  pmid    = {35921096},
  url     = {https://doi.org/10.1001/jamacardio.2022.2333}
}

@article{tunali2025-40081955,
  author  = {Tunali, Ilke and Wang, Jian and Arora, Anupa and Kim, Min Jung and Shcherbinin, Sergey and Pontecorvo, Michael J. and Iaccarino, Leonardo},
  title   = {{Development and Validation of a 18 F-Flortaucipir PET Visual Stratification Method}},
  journal = {Journal of Nuclear Medicine},
  year    = {2025},
  doi     = {10.2967/jnumed.124.268700},
  pmid    = {40081955},
  url     = {https://doi.org/10.2967/jnumed.124.268700}
}

@article{yokokura2011-20844871,
  author  = {Yokokura, M. and Mori, N. and Yagi, S. and Yoshikawa, E. and Kikuchi, M. and Yoshihara, Y. and Wakuda, T. and Sugihara, G. and others},
  title   = {{In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2011},
  doi     = {10.1007/s00259-010-1612-0},
  pmid    = {20844871},
  url     = {https://doi.org/10.1007/s00259-010-1612-0}
}

@article{siemers2023-36641606,
  author  = {Siemers, E. and Hitchcock, J. and Sundell, K. and Dean, R. and Jerecic, J. and Cline, E. and Iverson, K. and Moore, J. and others},
  title   = {{ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2023},
  doi     = {10.14283/jpad.2022.93},
  pmid    = {36641606},
  url     = {https://doi.org/10.14283/jpad.2022.93}
}

@article{honig2023-36949897,
  author  = {Honig, L. S. and Barakos, J. and Dhadda, S. and Kanekiyo, M. and Reyderman, L. and Irizarry, M. and Kramer, L. D. and Swanson, C. J. and others},
  title   = {{ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12377},
  pmid    = {36949897},
  url     = {https://doi.org/10.1002/trc2.12377}
}

@article{ketter2016-29199321,
  author  = {Ketter, N. and Liu, E. and Di, J. and Honig, L. S. and Lu, M. and Novak, G. and Werth, J. and LePrince Leterme, G. and others},
  title   = {{A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2016},
  doi     = {10.14283/jpad.2016.118},
  pmid    = {29199321},
  url     = {https://doi.org/10.14283/jpad.2016.118}
}

@article{west2017-29181488,
  author  = {West, T. and Hu, Y. and Verghese, P. B. and Bateman, R. J. and Braunstein, J. B. and Fogelman, I. and Budur, K. and Florian, H. and others},
  title   = {{Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2017},
  doi     = {10.14283/jpad.2017.36},
  pmid    = {29181488},
  url     = {https://doi.org/10.14283/jpad.2017.36}
}

@article{nowell2023-36258018,
  author  = {Nowell, J. and Blunt, E. and Edison, P.},
  title   = {{Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease}},
  journal = {Molecular psychiatry},
  year    = {2023},
  doi     = {10.1038/s41380-022-01792-4},
  pmid    = {36258018},
  url     = {https://doi.org/10.1038/s41380-022-01792-4}
}

@article{tuszynski2005-15852017,
  author  = {Tuszynski, M. H. and Thal, L. and Pay, M. and Salmon, D. P. and U, H. S. and Bakay, R. and Patel, P. and Blesch, A. and others},
  title   = {{A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease}},
  journal = {Nature medicine},
  year    = {2005},
  doi     = {10.1038/nm1239},
  pmid    = {15852017},
  url     = {https://doi.org/10.1038/nm1239}
}

@article{relkin2014-25546751,
  author  = {Relkin, Norman R.},
  title   = {{Intravenous immunoglobulin for Alzheimer's disease}},
  journal = {Clinical \& Experimental Immunology},
  year    = {2014},
  doi     = {10.1111/cei.12500},
  pmid    = {25546751},
  url     = {https://doi.org/10.1111/cei.12500}
}

@article{fillit2008-18675769,
  author  = {Fillit, H. and Nash, D. T. and Rundek, T. and Zuckerman, A.},
  title   = {{Cardiovascular risk factors and dementia}},
  journal = {The American journal of geriatric pharmacotherapy},
  year    = {2008},
  doi     = {10.1016/j.amjopharm.2008.06.004},
  pmid    = {18675769},
  url     = {https://doi.org/10.1016/j.amjopharm.2008.06.004}
}

@article{wahlberg2012-22655593,
  author  = {Wahlberg, L. U. and Lind, G. and Almqvist, P. M. and Kusk, P. and Tornøe, J. and Juliusson, B. and Söderman, M. and Selldén, E. and others},
  title   = {{Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery}},
  journal = {Journal of neurosurgery},
  year    = {2012},
  doi     = {10.3171/2012.2.jns11714},
  pmid    = {22655593},
  url     = {https://doi.org/10.3171/2012.2.jns11714}
}

@article{perry2003-12895683,
  author  = {Perry, N. S. and Bollen, C. and Perry, E. K. and Ballard, C.},
  title   = {{Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial}},
  journal = {Pharmacology, biochemistry, and behavior},
  year    = {2003},
  doi     = {10.1016/s0091-3057(03)00108-4},
  pmid    = {12895683},
  url     = {https://doi.org/10.1016/s0091-3057(03)00108-4}
}

@article{yu2025-40840993,
  author  = {Yu, Congcong and Yang, Huijie and Zhang, Bing and Chen, Shihua and Yang, Sijue and Li, Fangyi and Zhu, Wenhui and Zhai, Beibei and others},
  title   = {{Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase}},
  journal = {BMJ Open},
  year    = {2025},
  doi     = {10.1136/bmjopen-2024-095382},
  pmid    = {40840993},
  url     = {https://doi.org/10.1136/bmjopen-2024-095382}
}

@article{bittner2025-39887500,
  author  = {Bittner, Tobias and Tonietto, Matteo and Klein, Gregory and Belusov, Anton and Illiano, Vittorio and Voyle, Nicola and Delmar, Paul and Scelsi, Marzia A and others},
  title   = {{Biomarker treatment effects in two phase 3 trials of gantenerumab}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.14414},
  pmid    = {39887500},
  url     = {https://doi.org/10.1002/alz.14414}
}

@article{cummings2025-39971900,
  author  = {Cummings, Jeffrey L and Zhou, Yadi and Van Stone, Alexandra and Cammann, Davis and Tonegawa-Kuji, Reina and Fonseca, Jorge and Cheng, Feixiong},
  title   = {{Drug repurposing for Alzheimer's disease and other neurodegenerative disorders}},
  journal = {Nature communications},
  year    = {2025},
  doi     = {10.1038/s41467-025-56690-4},
  pmid    = {39971900},
  url     = {https://doi.org/10.1038/s41467-025-56690-4}
}

@article{smedinga2021-32809153,
  author  = {Smedinga, M. and Darweesh, S. K. L. and Bloem, B. R. and Post, B. and Richard, E.},
  title   = {{Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field}},
  journal = {Journal of neurology},
  year    = {2021},
  doi     = {10.1007/s00415-020-10162-5},
  pmid    = {32809153},
  url     = {https://doi.org/10.1007/s00415-020-10162-5}
}

@article{aarsland2003-14533126,
  author  = {Aarsland, D. and Hutchinson, M. and Larsen, J. P.},
  title   = {{Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia}},
  journal = {International journal of geriatric psychiatry},
  year    = {2003},
  doi     = {10.1002/gps.949},
  pmid    = {14533126},
  url     = {https://doi.org/10.1002/gps.949}
}

@article{cummings2019-31334330,
  author  = {Cummings, J. and Lee, G. and Ritter, A. and Sabbagh, M. and Zhong, K.},
  title   = {{Alzheimer's disease drug development pipeline: 2019}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.05.008},
  pmid    = {31334330},
  url     = {https://doi.org/10.1016/j.trci.2019.05.008}
}

@article{gueorguieva2023-37388759,
  author  = {Gueorguieva, Ivelina and Willis, Brian A and Chua, Laiyi and Chow, Kay and Ernest, C Steven and Wang, Jian and Shcherbinin, Sergey and Sims, John R and others},
  title   = {{Donanemab exposure and efficacy relationship using modeling in Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2023},
  doi     = {10.1002/trc2.12404},
  pmid    = {37388759},
  url     = {https://doi.org/10.1002/trc2.12404}
}

@article{santerre2026-42962966,
  author  = {Santerre, Maryline and Shcherbik, Natalia and Sawaya, Bassel E},
  title   = {{The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration}},
  journal = {Metabolism: clinical and experimental},
  year    = {2026},
  doi     = {10.1016/j.metabol.2026.156810},
  pmid    = {42962966},
  url     = {https://doi.org/10.1016/j.metabol.2026.156810}
}

@article{colucci2023-38027469,
  author  = {Colucci, Fabiana and Avenali, Micol and De Micco, Rosita and Poli, Marco Fusar and Cerri, Silvia and Stanziano, Mario and Bacila, Ana and Cuconato, Giada and others},
  title   = {{Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol}},
  journal = {BMJ neurology open},
  year    = {2023},
  doi     = {10.1136/bmjno-2023-000535},
  pmid    = {38027469},
  url     = {https://doi.org/10.1136/bmjno-2023-000535}
}

@article{friedman2021-33674360,
  author  = {Friedman, Lauren G and McKeehan, Nicholas and Hara, Yuko and Cummings, Jeffrey L and Matthews, Dawn C and Zhu, Jian and Mohs, Richard C and Wang, Deli and others},
  title   = {{Value-Generating Exploratory Trials in Neurodegenerative Dementias}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000011774},
  pmid    = {33674360},
  url     = {https://doi.org/10.1212/wnl.0000000000011774}
}

@article{henley2015-26120369,
  author  = {Henley, David B and Dowsett, Sherie A and Chen, Yun-Fei and Liu-Seifert, Hong and Grill, Joshua D and Doody, Rachelle S and Aisen, Paul and Raman, Rema and others},
  title   = {{Alzheimer's disease progression by geographical region in a clinical trial setting}},
  journal = {Alzheimer's research \& therapy},
  year    = {2015},
  doi     = {10.1186/s13195-015-0127-0},
  pmid    = {26120369},
  url     = {https://doi.org/10.1186/s13195-015-0127-0}
}

@article{tremblay2022-35751438,
  author  = {Tremblay, Cécilia and Serrano, Geidy E and Intorcia, Anthony J and Mariner, Monica R and Sue, Lucia I and Arce, Richard A and Atri, Alireza and Adler, Charles H and others},
  title   = {{Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment}},
  journal = {Journal of neuropathology and experimental neurology},
  year    = {2022},
  doi     = {10.1093/jnen/nlac042},
  pmid    = {35751438},
  url     = {https://doi.org/10.1093/jnen/nlac042}
}

@article{bae2024-38196636,
  author  = {Bae, Sua and Liu, Keyu and Pouliopoulos, Antonios N. and Ji, Robin and Jiménez-Gambín, Sergio and Yousefian, Omid and Kline-Schoder, Alina R. and Batts, Alec J. and others},
  title   = {{Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping}},
  journal = {Theranostics},
  year    = {2024},
  doi     = {10.7150/thno.94206},
  pmid    = {38196636},
  url     = {https://doi.org/10.7150/thno.94206}
}

@article{gonzales2025-40394335,
  author  = {Gonzales, M. M. and Garbarino, V. R. and Kautz, T. F. and Song, X. and Lopez-Cruzan, M. and Linehan, L. and Van Skike, C. E. and De Erausquin, G. A. and others},
  title   = {{Rapamycin treatment for Alzheimer's disease and related dementias: a pilot phase 1 clinical trial}},
  journal = {Communications medicine},
  year    = {2025},
  doi     = {10.1038/s43856-025-00904-9},
  pmid    = {40394335},
  url     = {https://doi.org/10.1038/s43856-025-00904-9}
}

@article{tianhuikwan2020-33321511,
  author  = {Tian Hui Kwan, A. and Arfaie, S. and Therriault, J. and Rosa-Neto, P. and Gauthier, S.},
  title   = {{Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2020},
  doi     = {10.1159/000511506},
  pmid    = {33321511},
  url     = {https://doi.org/10.1159/000511506}
}

@article{wischik2014-24361915,
  author  = {Wischik, C. M. and Harrington, C. R. and Storey, J. M.},
  title   = {{Tau-aggregation inhibitor therapy for Alzheimer's disease}},
  journal = {Biochemical pharmacology},
  year    = {2014},
  doi     = {10.1016/j.bcp.2013.12.008},
  pmid    = {24361915},
  url     = {https://doi.org/10.1016/j.bcp.2013.12.008}
}

@article{weber2020-31959733,
  author  = {Weber, G. E. and Koenig, K. A. and Khrestian, M. and Shao, Y. and Tuason, E. D. and Gramm, M. and Lal, D. and Leverenz, J. B. and others},
  title   = {{An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report}},
  journal = {Journal of immunology (Baltimore, Md. : 1950)},
  year    = {2020},
  doi     = {10.4049/jimmunol.1901166},
  pmid    = {31959733},
  url     = {https://doi.org/10.4049/jimmunol.1901166}
}

@article{borroni2001-11255448,
  author  = {Borroni, B. and Colciaghi, F. and Pastorino, L. and Pettenati, C. and Cottini, E. and Rozzini, L. and Monastero, R. and Lenzi, G. L. and others},
  title   = {{Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.442},
  pmid    = {11255448},
  url     = {https://doi.org/10.1001/archneur.58.3.442}
}

@article{edwards2007-17409748,
  author  = {Edwards, K. and Royall, D. and Hershey, L. and Lichter, D. and Hake, A. and Farlow, M. and Pasquier, F. and Johnson, S.},
  title   = {{Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2007},
  doi     = {10.1159/000101512},
  pmid    = {17409748},
  url     = {https://doi.org/10.1159/000101512}
}

@article{khartabil2025-39998021,
  author  = {Khartabil, N. and Awaness, A.},
  title   = {{Targeting Amyloid Pathology in Early Alzheimer's: The Promise of Donanemab-Azbt}},
  journal = {Pharmacy (Basel, Switzerland)},
  year    = {2025},
  doi     = {10.3390/pharmacy13010023},
  pmid    = {39998021},
  url     = {https://doi.org/10.3390/pharmacy13010023}
}

@article{rosselli2000-10775968,
  author  = {Rosselli, D. and Ardila, A. and Pradilla, G. and Morillo, L. and Bautista, L. and Rey, O. and Camacho, M.},
  title   = {{[The Mini-Mental State Examination as a selected diagnostic test for dementia: a Colombian population study. GENECO]}},
  journal = {Revista de neurologia},
  year    = {2000},
  doi     = {10.33588/rn.3005.99125},
  pmid    = {10775968},
  url     = {https://doi.org/10.33588/rn.3005.99125}
}

@article{mcnamara1998-9678319,
  author  = {McNamara, M. J. and Gomez-Isla, T. and Hyman, B. T.},
  title   = {{Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {1998},
  doi     = {10.1001/archneur.55.7.1001},
  pmid    = {9678319},
  url     = {https://doi.org/10.1001/archneur.55.7.1001}
}

@article{choi2011-21463871,
  author  = {Choi, J. and Lee, H. W. and Suk, K.},
  title   = {{Increased plasma levels of lipocalin 2 in mild cognitive impairment}},
  journal = {Journal of the neurological sciences},
  year    = {2011},
  doi     = {10.1016/j.jns.2011.03.023},
  pmid    = {21463871},
  url     = {https://doi.org/10.1016/j.jns.2011.03.023}
}

@article{seilhean1997-9144590,
  author  = {Seilhean, D. and Kobayashi, K. and He, Y. and Uchihara, T. and Rosenblum, O. and Katlama, C. and Bricaire, F. and Duyckaerts, C. and others},
  title   = {{Tumor necrosis factor-alpha, microglia and astrocytes in AIDS dementia complex}},
  journal = {Acta neuropathologica},
  year    = {1997},
  doi     = {10.1007/s004010050646},
  pmid    = {9144590},
  url     = {https://doi.org/10.1007/s004010050646}
}

@article{kim2015-29854930,
  author  = {Kim, H. J. and Seo, S. W. and Chang, J. W. and Lee, J. I. and Kim, C. H. and Chin, J. and Choi, S. J. and Kwon, H. and others},
  title   = {{Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: A phase 1 clinical trial}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2015},
  doi     = {10.1016/j.trci.2015.06.007},
  pmid    = {29854930},
  url     = {https://doi.org/10.1016/j.trci.2015.06.007}
}

@article{vaz2022-35611326,
  author  = {Vaz, M. and Silva, V. and Monteiro, C. and Silvestre, S.},
  title   = {{Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities}},
  journal = {Clinical interventions in aging},
  year    = {2022},
  doi     = {10.2147/cia.s325026},
  pmid    = {35611326},
  url     = {https://doi.org/10.2147/cia.s325026}
}

@article{yadollahikhales2023-37490245,
  author  = {Yadollahikhales, G. and Rojas, J. C.},
  title   = {{Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update}},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  year    = {2023},
  doi     = {10.1007/s13311-023-01405-0},
  pmid    = {37490245},
  url     = {https://doi.org/10.1007/s13311-023-01405-0}
}

@article{retout2022-35100444,
  author  = {Retout, S. and Gieschke, R. and Serafin, D. and Weber, C. and Frey, N. and Hofmann, C.},
  title   = {{Disease Modeling and Model-Based Meta-Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease}},
  journal = {Clinical pharmacology and therapeutics},
  year    = {2022},
  doi     = {10.1002/cpt.2535},
  pmid    = {35100444},
  url     = {https://doi.org/10.1002/cpt.2535}
}

@article{mega1999-10555660,
  author  = {Mega, M. S. and Masterman, D. M. and O'Connor, S. M. and Barclay, T. R. and Cummings, J. L.},
  title   = {{The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {1999},
  doi     = {10.1001/archneur.56.11.1388},
  pmid    = {10555660},
  url     = {https://doi.org/10.1001/archneur.56.11.1388}
}

@article{cummings2014-25024750,
  author  = {Cummings, J. L. and Morstorf, T. and Zhong, K.},
  title   = {{Alzheimer's disease drug-development pipeline: few candidates, frequent failures}},
  journal = {Alzheimer's research \& therapy},
  year    = {2014},
  doi     = {10.1186/alzrt269},
  pmid    = {25024750},
  url     = {https://doi.org/10.1186/alzrt269}
}

@article{suzuki2024-38945936,
  author  = {Suzuki, Naoyuki and Hatta, Takuya and Ito, Mana and Kusakabe, Ken-Ichi},
  title   = {{Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer's Disease: Recent Advances and Perspectives}},
  journal = {Chemical \& pharmaceutical bulletin},
  year    = {2024},
  doi     = {10.1248/cpb.c24-00069},
  pmid    = {38945936},
  url     = {https://doi.org/10.1248/cpb.c24-00069}
}

@article{park2024-38932758,
  author  = {Park, Kyung Won},
  title   = {{Anti-amyloid Antibody Therapies for Alzheimer's Disease}},
  journal = {Nuclear medicine and molecular imaging},
  year    = {2024},
  doi     = {10.1007/s13139-024-00848-3},
  pmid    = {38932758},
  url     = {https://doi.org/10.1007/s13139-024-00848-3}
}

@article{shinohara2024-39370836,
  author  = {Shinohara, Moeko and Ono, Kenjiro},
  title   = {{[Anti-Amyloid Antibody Therapy for Alzheimer's Disease]}},
  journal = {Brain and nerve = Shinkei kenkyu no shinpo},
  year    = {2024},
  doi     = {10.11477/mf.1416202747},
  pmid    = {39370836},
  url     = {https://doi.org/10.11477/mf.1416202747}
}

@article{imbimbo2025-39623197,
  author  = {Imbimbo, Camillo and Ramusino, Matteo Cotta and Leone, Silvia and Mazzacane, Federico and De Franco, Valentino and Gatti, Alberto and Perini, Giulia and Costa, Alfredo},
  title   = {{Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease}},
  journal = {CNS drugs},
  year    = {2025},
  doi     = {10.1007/s40263-024-01133-9},
  pmid    = {39623197},
  url     = {https://doi.org/10.1007/s40263-024-01133-9}
}

@article{miyazaki2024-39251226,
  author  = {Miyazaki, Takehiro and Higashi, Shinji and Arai, Tetsuaki},
  title   = {{[Disease-modifying Drugs for non-Alzheimer Dementias]}},
  journal = {Brain and nerve = Shinkei kenkyu no shinpo},
  year    = {2024},
  doi     = {10.11477/mf.1416202733},
  pmid    = {39251226},
  url     = {https://doi.org/10.11477/mf.1416202733}
}

@article{brodtmann2023-36934371,
  author  = {Brodtmann, Amy G. and Darby, David and Oboudiyat, Carly and Mahoney, Colin and Le Heron, Campbell J. and Panegyres, Peter K. and Brew, Bruce J.},
  title   = {{Assessing preparedness for Alzheimer disease‐modifying therapies in Australasian health care systems}},
  journal = {The Medical Journal of Australia},
  year    = {2023},
  doi     = {10.5694/mja2.51880},
  pmid    = {36934371},
  url     = {https://doi.org/10.5694/mja2.51880}
}

@article{zack2015-2d3045db,
  author  = {Zack, Julia and Berg, Jolene and Juan, Axel and Pannacciulli, Nicola and Allard, Martine and Gottwald, Mildred and Zhang, Heather and Shao, Yongwu and others},
  title   = {{Pharmacokinetic drug–drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus}},
  journal = {Clinical Pharmacology in Drug Development},
  year    = {2015},
  doi     = {10.1002/cpdd.174},
  url     = {https://doi.org/10.1002/cpdd.174}
}

@article{meier2018-29853653,
  author  = {Meier, SR. and Syvänen, S. and Hultqvist, G. and Fang, X. T. and Roshanbin, S. and Lannfelt, L. and Neumann, U. and Sehlin, D.},
  title   = {{Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2018},
  doi     = {10.2967/jnumed.118.213140},
  pmid    = {29853653},
  url     = {https://doi.org/10.2967/jnumed.118.213140}
}

@article{jeppsson2012-23048024,
  author  = {Jeppsson, F. and Eketjäll, S. and Janson, J. and Karlström, S. and Gustavsson, S. and Olsson, L. L. and Radesäter, A. C. and Ploeger, B. and others},
  title   = {{Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease}},
  journal = {The Journal of biological chemistry},
  year    = {2012},
  doi     = {10.1074/jbc.m112.409110},
  pmid    = {23048024},
  url     = {https://doi.org/10.1074/jbc.m112.409110}
}

@article{kaufer1996-8679057,
  author  = {Kaufer, D. I. and Cummings, J. L. and Christine, D.},
  title   = {{Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study}},
  journal = {Journal of geriatric psychiatry and neurology},
  year    = {1996},
  doi     = {10.1177/089198879600900101},
  pmid    = {8679057},
  url     = {https://doi.org/10.1177/089198879600900101}
}

@article{polito2026-41669531,
  author  = {Polito, Cristina and Martinelli, Giulia and Della Bella, Sara and Pavan, Eleonora and Crocetto, Ylenia and Abagnale, Simona and Rondoni, Cristiana and Voscarelli, Alfonso and others},
  title   = {{Integrated bio-cooperative robotic platform for virtual cognitive training in Parkinson's disease: design and methodology of the OPERA project}},
  journal = {Frontiers in Neurology},
  year    = {2026},
  doi     = {10.3389/fneur.2025.1680215},
  pmid    = {41669531},
  url     = {https://doi.org/10.3389/fneur.2025.1680215}
}

@article{wootla2015-26389734,
  author  = {Wootla, B. and Watzlawik, J. O. and Warrington, A. E. and Wittenberg, N. J. and Denic, A. and Xu, X. and Jordan, L. R. and Papke, L. M. and others},
  title   = {{Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2015.2188},
  pmid    = {26389734},
  url     = {https://doi.org/10.1001/jamaneurol.2015.2188}
}

@article{lobo1995-7771920,
  author  = {Lobo, A. and Saz, P. and Marcos, G. and Día, J. L. and De-la-Cámara, C.},
  title   = {{The prevalence of dementia and depression in the elderly community in a southern European population. The Zaragoza study}},
  journal = {Archives of general psychiatry},
  year    = {1995},
  doi     = {10.1001/archpsyc.1995.03950180083011},
  pmid    = {7771920},
  url     = {https://doi.org/10.1001/archpsyc.1995.03950180083011}
}

@article{cummings2025-41145337,
  author  = {Cummings, Jeffrey L. and Burstein, Aaron H. and Fillit, Howard M.},
  title   = {{Alzheimer Combination Therapies: Overview and Scenarios}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100328},
  pmid    = {41145337},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100328}
}

@article{howard2025-40536945,
  author  = {Howard, Calvin and Johnson, Amy M and Peedicail, Joseph Samuel and Ng, Marcus},
  title   = {{The Rapid Online Cognitive Assessment for the Detection of Neurocognitive Disorder: Open-Label Study}},
  journal = {Journal of Medical Internet Research},
  year    = {2025},
  doi     = {10.2196/66735},
  pmid    = {40536945},
  url     = {https://doi.org/10.2196/66735}
}

@article{davies1997-9258891,
  author  = {Davies, T. A. and Long, H. J. and Sgro, K. and Rathbun, W. H. and McMenamin, M. E. and Seetoo, K. and Tibbles, H. and Billingslea, A. M. and others},
  title   = {{Activated Alzheimer disease platelets retain more beta amyloid precursor protein}},
  journal = {Neurobiology of aging},
  year    = {1997},
  doi     = {10.1016/s0197-4580(97)00013-4},
  pmid    = {9258891},
  url     = {https://doi.org/10.1016/s0197-4580(97)00013-4}
}

@article{chun2022-35184428,
  author  = {Chun, M. Y. and Lee, J. and Jeong, J. H. and Roh, J. H. and Oh, S. J. and Oh, M. and Oh, J. S. and others},
  title   = {{18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment}},
  journal = {Yonsei medical journal},
  year    = {2022},
  doi     = {10.3349/ymj.2022.63.3.259},
  pmid    = {35184428},
  url     = {https://doi.org/10.3349/ymj.2022.63.3.259}
}

@article{avison2004-15579291,
  author  = {Avison, M. J. and Nath, A. and Greene-Avison, R. and Schmitt, F. A. and Greenberg, R. N. and Berger, JR.},
  title   = {{Neuroimaging correlates of HIV-associated BBB compromise}},
  journal = {Journal of neuroimmunology},
  year    = {2004},
  doi     = {10.1016/j.jneuroim.2004.08.025},
  pmid    = {15579291},
  url     = {https://doi.org/10.1016/j.jneuroim.2004.08.025}
}

@article{tolar2020-32787971,
  author  = {Tolar, M. and Abushakra, S. and Hey, J. A. and Porsteinsson, A. and Sabbagh, M.},
  title   = {{Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval}},
  journal = {Alzheimer's research \& therapy},
  year    = {2020},
  doi     = {10.1186/s13195-020-00663-w},
  pmid    = {32787971},
  url     = {https://doi.org/10.1186/s13195-020-00663-w}
}

@article{nelissen2009-19617318,
  author  = {Nelissen, N. and Van Laere, K. and Thurfjell, L. and Owenius, R. and Vandenbulcke, M. and Koole, M. and Bormans, G. and Brooks, D. J. and others},
  title   = {{Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2009},
  doi     = {10.2967/jnumed.109.063305},
  pmid    = {19617318},
  url     = {https://doi.org/10.2967/jnumed.109.063305}
}

@article{arndt2018-29686315,
  author  = {Arndt, J. W. and Qian, F. and Smith, B. A. and Quan, C. and Kilambi, K. P. and Bush, M. W. and Walz, T. and Pepinsky, R. B. and others},
  title   = {{Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β}},
  journal = {Scientific reports},
  year    = {2018},
  doi     = {10.1038/s41598-018-24501-0},
  pmid    = {29686315},
  url     = {https://doi.org/10.1038/s41598-018-24501-0}
}

@article{tolar2020-31706733,
  author  = {Tolar, M. and Abushakra, S. and Sabbagh, M.},
  title   = {{The path forward in Alzheimer's disease therapeutics: Reevaluating the amyloid cascade hypothesis}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1016/j.jalz.2019.09.075},
  pmid    = {31706733},
  url     = {https://doi.org/10.1016/j.jalz.2019.09.075}
}

@article{doggrell2024-38414336,
  author  = {Doggrell, S. A.},
  title   = {{More failure with solanezumab - this time in preclinical Alzheimer's disease}},
  journal = {Expert opinion on biological therapy},
  year    = {2024},
  doi     = {10.1080/14712598.2024.2325551},
  pmid    = {38414336},
  url     = {https://doi.org/10.1080/14712598.2024.2325551}
}

@article{frisoni2017-28721928,
  author  = {Frisoni, G. B. and Boccardi, M. and Barkhof, F. and Blennow, K. and Cappa, S. and Chiotis, K. and Démonet, J. F. and others},
  title   = {{Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers}},
  journal = {The Lancet. Neurology},
  year    = {2017},
  doi     = {10.1016/s1474-4422(17)30159-x},
  pmid    = {28721928},
  url     = {https://doi.org/10.1016/s1474-4422(17)30159-x}
}

@article{bateman2022-36447240,
  author  = {Bateman, Randall J and Cummings, Jeffrey and Schobel, Scott and Salloway, Stephen and Vellas, Bruno and Boada, Mercè and Black, Sandra E and Blennow, Kaj and others},
  title   = {{Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-022-01110-8},
  pmid    = {36447240},
  url     = {https://doi.org/10.1186/s13195-022-01110-8}
}

@article{devanand2023-37639488,
  author  = {Devanand, D P},
  title   = {{Management of neuropsychiatric symptoms in dementia}},
  journal = {Current opinion in neurology},
  year    = {2023},
  doi     = {10.1097/wco.0000000000001199},
  pmid    = {37639488},
  url     = {https://doi.org/10.1097/wco.0000000000001199}
}

@article{johannesson2021-34091073,
  author  = {Johannesson, Malin and Sahlin, Charlotte and Söderberg, Linda and Basun, Hans and Fälting, Johanna and Möller, Christer and Zachrisson, Olof and Sunnemark, Dan and others},
  title   = {{Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease}},
  journal = {Molecular and cellular neurosciences},
  year    = {2021},
  doi     = {10.1016/j.mcn.2021.103641},
  pmid    = {34091073},
  url     = {https://doi.org/10.1016/j.mcn.2021.103641}
}

@article{sabbagh2020-33135288,
  author  = {Sabbagh, Marwan Noel and Cummings, Jeffrey L.},
  title   = {{Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019”}},
  journal = {Alzheimer s \& Dementia},
  year    = {2020},
  doi     = {10.1002/alz.12235},
  pmid    = {33135288},
  url     = {https://doi.org/10.1002/alz.12235}
}

@article{boxer2023-37848035,
  author  = {Boxer, A. L. and Sperling, R.},
  title   = {{Accelerating Alzheimer's therapeutic development: The past and future of clinical trials}},
  journal = {Cell},
  year    = {2023},
  doi     = {10.1016/j.cell.2023.09.023},
  pmid    = {37848035},
  url     = {https://doi.org/10.1016/j.cell.2023.09.023}
}

@article{lannfelt2014-25031633,
  author  = {Lannfelt, L. and Möller, C. and Basun, H. and Osswald, G. and Sehlin, D. and Satlin, A. and Logovinsky, V. and Gellerfors, P.},
  title   = {{Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2014},
  doi     = {10.1186/alzrt246},
  pmid    = {25031633},
  url     = {https://doi.org/10.1186/alzrt246}
}

@article{vellas2013-23809364,
  author  = {Vellas, B. and Carrillo, M. C. and Sampaio, C. and Brashear, H. R. and Siemers, E. and Hampel, H. and Schneider, L. S. and Weiner, M. and others},
  title   = {{Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2013.03.007},
  pmid    = {23809364},
  url     = {https://doi.org/10.1016/j.jalz.2013.03.007}
}

@article{yuksel2022-35879846,
  author  = {Yuksel, J. M. and Noviasky, J. and Britton, S.},
  title   = {{Aducanumab for Alzheimer's Disease: Summarized Data From EMERGE, ENGAGE, and PRIME Studies}},
  journal = {The Senior care pharmacist},
  year    = {2022},
  doi     = {10.4140/tcp.n.2022.329},
  pmid    = {35879846},
  url     = {https://doi.org/10.4140/tcp.n.2022.329}
}

@article{ayalon2021-33980574,
  author  = {Ayalon, G. and Lee, S. H. and Adolfsson, O. and Foo-Atkins, C. and Atwal, J. K. and Blendstrup, M. and Booler, H. and Bravo, J. and others},
  title   = {{Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease}},
  journal = {Science translational medicine},
  year    = {2021},
  doi     = {10.1126/scitranslmed.abb2639},
  pmid    = {33980574},
  url     = {https://doi.org/10.1126/scitranslmed.abb2639}
}

@article{wang2023-37730113,
  author  = {Wang, Z. J. and Li, X. R. and Chai, S. F. and Li, W. R. and Li, S. and Hou, M. and Li, J. L. and Ye, Y. C. and others},
  title   = {{Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway}},
  journal = {Neuropharmacology},
  year    = {2023},
  doi     = {10.1016/j.neuropharm.2023.109716},
  pmid    = {37730113},
  url     = {https://doi.org/10.1016/j.neuropharm.2023.109716}
}

@article{lachno2011-21694458,
  author  = {Lachno, D. R. and Romeo, M. J. and Siemers, E. R. and Vanderstichele, H. and Coart, E. and Konrad, R. J. and Zajac, J. J. and Talbot, J. A. and others},
  title   = {{Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2011},
  doi     = {10.3233/jad-2011-110296},
  pmid    = {21694458},
  url     = {https://doi.org/10.3233/jad-2011-110296}
}

@article{aisen2003-12611755,
  author  = {Aisen, P. S. and Egelko, S. and Andrews, H. and Diaz-Arrastia, R. and Weiner, M. and DeCarli, C. and Jagust, W. and Miller, J. W. and others},
  title   = {{A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2003},
  doi     = {10.1176/appi.ajgp.11.2.246},
  pmid    = {12611755},
  url     = {https://doi.org/10.1176/appi.ajgp.11.2.246}
}

@article{davtyan2019-31847886,
  author  = {Davtyan, H. and Hovakimyan, A. and Kiani Shabestari, S. and Antonyan, T. and Coburn, M. A. and Zagorski, K. and Chailyan, G. and Petrushina, I. and others},
  title   = {{Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0556-2},
  pmid    = {31847886},
  url     = {https://doi.org/10.1186/s13195-019-0556-2}
}

@article{marasco2020-32840330,
  author  = {Marasco, R. A.},
  title   = {{Current and evolving treatment strategies for the Alzheimer disease continuum}},
  journal = {The American journal of managed care},
  year    = {2020},
  doi     = {10.37765/ajmc.2020.88481},
  pmid    = {32840330},
  url     = {https://doi.org/10.37765/ajmc.2020.88481}
}

@article{cline2025-39955261,
  author  = {Cline, Erika N. and Antwi‐Berko, Daniel and Sundell, Karen L. and Johnson, Elizabeth A. and Hyland, Maddelyn and Zhang, Hao and Vanderstichele, Hugo and Kaplow, June M. and others},
  title   = {{Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100082},
  pmid    = {39955261},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100082}
}

@article{cummings2019-31062825,
  author  = {Cummings, J and Blennow, K and Johnson, K and Keeley, M and Bateman, R J and Molinuevo, J L and Touchon, J and Aisen, P and others},
  title   = {{Anti-Tau Trials for Alzheimer's Disease: A Report from the EU/US/CTAD Task Force}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2019},
  doi     = {10.14283/jpad.2019.14},
  pmid    = {31062825},
  url     = {https://doi.org/10.14283/jpad.2019.14}
}

@article{giagkou2019-31007097,
  author  = {Giagkou, Nikolaos and Stamelou, Maria},
  title   = {{Emerging drugs for progressive supranuclear palsy}},
  journal = {Expert opinion on emerging drugs},
  year    = {2019},
  doi     = {10.1080/14728214.2019.1609450},
  pmid    = {31007097},
  url     = {https://doi.org/10.1080/14728214.2019.1609450}
}

@article{jiang2019-31667754,
  author  = {Jiang, Jie and Ravits, John},
  title   = {{Pathogenic Mechanisms and Therapy Development for C9orf72 Amyotrophic Lateral Sclerosis/Frontotemporal Dementia}},
  journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics},
  year    = {2019},
  doi     = {10.1007/s13311-019-00797-2},
  pmid    = {31667754},
  url     = {https://doi.org/10.1007/s13311-019-00797-2}
}

@article{riedel2020-32091331,
  author  = {Riedel, Gernot and Klein, Jochen and Niewiadomska, Grazyna and Kondak, Constantin and Schwab, Karima and Lauer, Dilyara and Magbagbeolu, Mandy and Steczkowska, Marta and others},
  title   = {{Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model}},
  journal = {Current Alzheimer research},
  year    = {2020},
  doi     = {10.2174/1567205017666200224120926},
  pmid    = {32091331},
  url     = {https://doi.org/10.2174/1567205017666200224120926}
}

@article{bankole2020-32162529,
  author  = {Bankole, Azziza and Anderson, Martha S and Homdee, Nutta and Alam, Ridwan and Lofton, Ashley and Fyffe, Nykesha and Goins, Hilda and Newbold, Temple and others},
  title   = {{BESI: Behavioral and Environmental Sensing and Intervention for Dementia Caregiver Empowerment-Phases 1 and 2}},
  journal = {American journal of Alzheimer's disease and other dementias},
  year    = {2020},
  doi     = {10.1177/1533317520906686},
  pmid    = {32162529},
  url     = {https://doi.org/10.1177/1533317520906686}
}

@article{dudman2018-29444736,
  author  = {Dudman, Jenny and Meyer, Julienne and Holman, Cheryl and Moyle, Wendy},
  title   = {{Recognition of the complexity facing residential care homes: a practitioner inquiry}},
  journal = {Primary health care research \& development},
  year    = {2018},
  doi     = {10.1017/s1463423618000105},
  pmid    = {29444736},
  url     = {https://doi.org/10.1017/s1463423618000105}
}

@article{study2021-38d83515,
  title   = {{Donanemab leads to less decline in early Alzheimer's disease}},
  journal = {The Brown University Psychopharmacology Update},
  year    = {2021},
  doi     = {10.1002/pu.30739},
  url     = {https://doi.org/10.1002/pu.30739}
}

@article{malhotra2025-41543360,
  author  = {Malhotra, Chetna and Yue, Yanzhen and Ramakrishnan, Chandrika and Shah, Shimoni Urvish and Chen, Wenda and Yap, Philip Lin Kiat and Cheong, Chin Yee and Teo, Irene and others},
  title   = {{Supporting Dementia Caregiving With a Mobile Care Ecosystem: Development and Mixed Methods Study}},
  journal = {JMIR Aging},
  year    = {2025},
  doi     = {10.2196/78759},
  pmid    = {41543360},
  url     = {https://doi.org/10.2196/78759}
}

@article{seltzer2007-17953456,
  author  = {Seltzer, Ben},
  title   = {{Is long-term treatment of Alzheimer's disease with cholinesterase inhibitor therapy justified?}},
  journal = {Drugs \& aging},
  year    = {2007},
  doi     = {10.2165/00002512-200724110-00001},
  pmid    = {17953456},
  url     = {https://doi.org/10.2165/00002512-200724110-00001}
}

@article{waldemar2001-19811041,
  author  = {Waldemar, G},
  title   = {{Donepezil in the treatment of patients with Alzheimer's disease}},
  journal = {Expert review of neurotherapeutics},
  year    = {2001},
  doi     = {10.1586/14737175.1.1.11},
  pmid    = {19811041},
  url     = {https://doi.org/10.1586/14737175.1.1.11}
}

@article{jones2010-20836898,
  author  = {Jones, Roy W},
  title   = {{Dimebon disappointment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2010},
  doi     = {10.1186/alzrt49},
  pmid    = {20836898},
  url     = {https://doi.org/10.1186/alzrt49}
}

@article{riedmann2012-22914446,
  author  = {Riedmann, Eva M},
  title   = {{Two new combination pediatric vaccines advancing to use in infants}},
  journal = {Human vaccines \& immunotherapeutics},
  year    = {2012},
  doi     = {10.4161/hv.21700},
  pmid    = {22914446},
  url     = {https://doi.org/10.4161/hv.21700}
}

@article{fick2000-10776167,
  author  = {Fick, D. and Foreman, M.},
  title   = {{Consequences of not recognizing delirium superimposed on dementia in hospitalized elderly individuals}},
  journal = {Journal of gerontological nursing},
  year    = {2000},
  doi     = {10.3928/0098-9134-20000101-09},
  pmid    = {10776167},
  url     = {https://doi.org/10.3928/0098-9134-20000101-09}
}

@article{rhodus2025-40621818,
  author  = {Rhodus, Elizabeth K. and Kryscio, Richard and Jicha, Gregory A. and Baum, Carolyn Manville and Henley, Laura and Fairchild, Vickie and Roberts, Celeste and Gibson, Allison},
  title   = {{Creating harmony at home via environmental cueing: A feasibility trial of a non‐pharmacological intervention for rural caregivers of persons with dementia}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70405},
  pmid    = {40621818},
  url     = {https://doi.org/10.1002/alz.70405}
}

@article{basun2002-12218259,
  author  = {Basun, H. and Nilsberth, C. and Eckman, C. and Lannfelt, L. and Younkin, S.},
  title   = {{Plasma levels of Abeta42 and Abeta40 in Alzheimer patients during treatment with the acetylcholinesterase inhibitor tacrine}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2002},
  doi     = {10.1159/000063605},
  pmid    = {12218259},
  url     = {https://doi.org/10.1159/000063605}
}

@article{bhagunde2026-41543367,
  author  = {Bhagunde, Pratik R. and Penner, Natasha and Willis, Brian A. and Bell, Robert and Charil, Arnaud and Irizarry, Michael C. and Hersch, Steven J. and Reyderman, Larisa},
  title   = {{Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR ‐ SB Utilizing Semi‐Mechanistic Model}},
  journal = {CPT Pharmacometrics \& Systems Pharmacology},
  year    = {2026},
  doi     = {10.1002/psp4.70173},
  pmid    = {41543367},
  url     = {https://doi.org/10.1002/psp4.70173}
}

@article{wang2025-40911712,
  author  = {Wang, Guoqiao and Li, Yan and McDade, Eric and Xiong, Chengjie and Hartz, Sarah M. and Bateman, Randall John and Morris, John C. and Schneider, Lon S. S. and others},
  title   = {{Clinical progression on CDR‐SB©: Progression‐free time at each 0.5 unit level in dominantly inherited and sporadic Alzheimer's disease populations}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70643},
  pmid    = {40911712},
  url     = {https://doi.org/10.1002/alz.70643}
}

@article{aaron2022-35234657,
  author  = {Aaron, Gilson and Michele, Gassman and Debby, Dodds and Robin, Lombardo and Ford Ii James, H. and Michael, Potteiger},
  title   = {{Refining a Digital Therapeutic Platform for Home Care Agencies in Dementia Care to Elicit Stakeholder Feedback: Focus Group Study With Stakeholders}},
  journal = {JMIR aging},
  year    = {2022},
  doi     = {10.2196/32516},
  pmid    = {35234657},
  url     = {https://doi.org/10.2196/32516}
}

@article{piazza2016-27031492,
  author  = {Piazza, F. and Winblad, B.},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-160122},
  pmid    = {27031492},
  url     = {https://doi.org/10.3233/jad-160122}
}

@article{yang2015-25860060,
  author  = {Yang, C. and Xiao, S.},
  title   = {{New developments of clinical trial in immunotherapy for Alzheimer's disease}},
  journal = {Current pharmaceutical biotechnology},
  year    = {2015},
  doi     = {10.2174/138920101606150407112319},
  pmid    = {25860060},
  url     = {https://doi.org/10.2174/138920101606150407112319}
}

@article{athauda2016-26851597,
  author  = {Athauda, D. and Foltynie, T.},
  title   = {{The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action}},
  journal = {Drug discovery today},
  year    = {2016},
  doi     = {10.1016/j.drudis.2016.01.013},
  pmid    = {26851597},
  url     = {https://doi.org/10.1016/j.drudis.2016.01.013}
}

@article{chen2006-16805772,
  author  = {Chen, H. S. and Lipton, S. A.},
  title   = {{The chemical biology of clinically tolerated NMDA receptor antagonists}},
  journal = {Journal of neurochemistry},
  year    = {2006},
  doi     = {10.1111/j.1471-4159.2006.03991.x},
  pmid    = {16805772},
  url     = {https://doi.org/10.1111/j.1471-4159.2006.03991.x}
}

@article{salomone2012-22035455,
  author  = {Salomone, S. and Caraci, F. and Leggio, G. M. and Fedotova, J. and Drago, F.},
  title   = {{New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs}},
  journal = {British journal of clinical pharmacology},
  year    = {2012},
  doi     = {10.1111/j.1365-2125.2011.04134.x},
  pmid    = {22035455},
  url     = {https://doi.org/10.1111/j.1365-2125.2011.04134.x}
}

@article{lipton2005-15974913,
  author  = {Lipton, S. A.},
  title   = {{The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism}},
  journal = {Current Alzheimer research},
  year    = {2005},
  doi     = {10.2174/1567205053585846},
  pmid    = {15974913},
  url     = {https://doi.org/10.2174/1567205053585846}
}

@article{fuchslacelle2004-14999652,
  author  = {Fuchs-Lacelle, S. and Hadjistavropoulos, T.},
  title   = {{Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC)}},
  journal = {Pain management nursing : official journal of the American Society of Pain Management Nurses},
  year    = {2004},
  doi     = {10.1016/j.pmn.2003.10.001},
  pmid    = {14999652},
  url     = {https://doi.org/10.1016/j.pmn.2003.10.001}
}

@article{bonelli2004-15076012,
  author  = {Bonelli, R. M. and Wenning, G. K. and Kapfhammer, H. P.},
  title   = {{Huntington's disease: present treatments and future therapeutic modalities}},
  journal = {International clinical psychopharmacology},
  year    = {2004},
  doi     = {10.1097/00004850-200403000-00001},
  pmid    = {15076012},
  url     = {https://doi.org/10.1097/00004850-200403000-00001}
}

@article{elghanam2024-38669547,
  author  = {Elghanam, Y. and Purja, S. and Kim, E. Y.},
  title   = {{Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2024},
  doi     = {10.3233/jad-240008},
  pmid    = {38669547},
  url     = {https://doi.org/10.3233/jad-240008}
}

@article{muralidharan2022-35285968,
  author  = {Muralidharan, K. K. and Karumanchi, S. and Kowalski, K. G. and Burkett, P. and Chapel, S. and Rajagovindan, R. and Nestorov, I.},
  title   = {{A Time-to-Event Exposure-Response Model for Amyloid-Related Imaging Abnormalities Following Administration of Aducanumab to Subjects With Early Alzheimer Disease}},
  journal = {Journal of clinical pharmacology},
  year    = {2022},
  doi     = {10.1002/jcph.2047},
  pmid    = {35285968},
  url     = {https://doi.org/10.1002/jcph.2047}
}

@article{huventgrelle2025-972a008a,
  author  = {Huvent‐Grelle, Dominique and HABIB, Nicolas and Puisieux, François L.},
  title   = {{Anti-amyloid immunotherapies for Alzheimer’s disease old people: eligibility and real life in a geriatric memory clinic in Lille (France)}},
  journal = {La Revue de gériatrie},
  year    = {2025},
  doi     = {10.62581/revgeri.21682},
  url     = {https://doi.org/10.62581/revgeri.21682}
}

@article{fitzgerald2025-41414790,
  author  = {Fitzgerald, Kathryn W. and Fyfe, Katrina P. and Thompson, Sandra Claire},
  title   = {{Development of a Rural and Remote Dementia Training Framework}},
  journal = {Australian Journal of Rural Health},
  year    = {2025},
  doi     = {10.1111/ajr.70133},
  pmid    = {41414790},
  url     = {https://doi.org/10.1111/ajr.70133}
}

@article{raja2026-d1c44bbc,
  author  = {Raja, Michelle and Patel, Khush and Krish, Pranav and Chow, Chrissy and Azam, Zaki},
  title   = {{GLP-1 Receptor Agonists Beyond Glycemic Control: Clinical Implications in Neurodegenerative Disease and Substance Use Disorders}},
  journal = {Journal of Community Hospital Internal Medicine Perspectives},
  year    = {2026},
  doi     = {10.55729/2000-9666.1651},
  url     = {https://doi.org/10.55729/2000-9666.1651}
}

@article{chiungchih2021-34506009,
  author  = {Chiung-Chih, Chang and Lung, Chan and Hsi-Hsien, Chou and Yu-Wan, Yang and Ta-Fu, Chen and Ting-Bin, Chen and Chin-I, Chen and Audrey, Yang and others},
  title   = {{Effectiveness of the 10 cm2 Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study}},
  journal = {Advances in therapy},
  year    = {2021},
  doi     = {10.1007/s12325-021-01893-6},
  pmid    = {34506009},
  url     = {https://doi.org/10.1007/s12325-021-01893-6}
}

@article{dirks2025-41451623,
  author  = {Dirks, Bryan and Friend, Samantha and Howell, Becky and Murphy, Christine M and Zhang, Peter M and Feng, Xiaoshu and Pathak, Sanjeev S},
  title   = {{Plasma Biomarker Characterization of Alzheimer’s Disease Psychosis in Study ACP‐204‐006}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_106556},
  pmid    = {41451623},
  url     = {https://doi.org/10.1002/alz70859_106556}
}

@article{nahal2026-41810890,
  author  = {Nahal, Danica Juričić and Mas, Petar and Cegec, Ivana and Bego, Margareta and Domjanović, Iva Klarica},
  title   = {{Anti‐amyloid antibodies in Europe: Where are we now?}},
  journal = {British Journal of Clinical Pharmacology},
  year    = {2026},
  doi     = {10.1002/bcp.70526},
  pmid    = {41810890},
  url     = {https://doi.org/10.1002/bcp.70526}
}

@article{zanjani2025-40223630,
  author  = {Zanjani, Faika A. K. and Rhodes, Annie and O'Donnell, Kennedy and Hawks, Cate and Boling, Peter A. and Slattum, Patricia W. and Price, Elvin T. and Parsons, Pamela L. and others},
  title   = {{Community Input for Addressing Dementia Health Disparities: Richmond Brain Health Initiative}},
  journal = {Progress in community health partnerships},
  year    = {2025},
  doi     = {10.1353/cpr.2025.a956599},
  pmid    = {40223630},
  url     = {https://doi.org/10.1353/cpr.2025.a956599}
}

@article{doherty2022-35622461,
  author  = {Doherty, T. and Gee, M. and Maruff, P. and Smith, R. and Murphy, J. and Marsh, J. and Koschalka, L. and Martinez, M. and others},
  title   = {{Increasing the Cognitive Screening Efficiency of Global Phase III Trials in Early Alzheimer Disease: The Cognitive Task Force}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2022},
  doi     = {10.1097/wad.0000000000000508},
  pmid    = {35622461},
  url     = {https://doi.org/10.1097/wad.0000000000000508}
}

@article{ishibashi2025-40108731,
  author  = {Ishibashi, Kenji and Kurihara, Masanori and Ihara, Ryoko},
  title   = {{Both Amyloid and Tau Assessments Are Desired Before Initiating Disease-modifying Therapy for Alzheimer Disease: Three Real-world Cases}},
  journal = {Clinical Nuclear Medicine},
  year    = {2025},
  doi     = {10.1097/rlu.0000000000005842},
  pmid    = {40108731},
  url     = {https://doi.org/10.1097/rlu.0000000000005842}
}

@article{tato2022-35468638,
  author  = {Tatò, M. and Perneczky, R.},
  title   = {{[Diagnosing Alzheimer's dementia - a playground for academics or a sensible clinical measure?]}},
  journal = {Deutsche medizinische Wochenschrift (1946)},
  year    = {2022},
  doi     = {10.1055/a-1769-1376},
  pmid    = {35468638},
  url     = {https://doi.org/10.1055/a-1769-1376}
}

@article{study1993-8023065,
  title   = {{[Screening for mutations of the precursor of beta-amyloid protein in early forms of Alzheimer disease. French Study Group of Alzheimer Disease]}},
  journal = {Revue neurologique},
  year    = {1993},
  pmid    = {8023065}
}

@article{vanacore2021-34263875,
  author  = {Vanacore, N. and Blasimme, A. and Canevelli, M.},
  title   = {{[Aducanumab and Alzheimer's disease: a critical reflection.]}},
  journal = {Recenti progressi in medicina},
  year    = {2021},
  doi     = {10.1701/3638.36183},
  pmid    = {34263875},
  url     = {https://doi.org/10.1701/3638.36183}
}

@article{study2024-c943abc5,
  title   = {{UCB Presents Data on Bepranemab (anti-tau antibody) in Early Alzheimer's Disease: Phase 2a TOGETHER Study}},
  journal = {UCB press release (data presented at CTAD 2024)},
  year    = {2024}
}

@article{klein2025-b9ea469a,
  author  = {Klein, G. and Rabinovici, G. D. and Zetterberg, H. and others},
  title   = {{Interim biomarker results for trontinemab, a novel Brainshuttle antibody in development for the treatment of Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia (AAIC 2025 conference abstract)},
  year    = {2025}
}

@article{cohen2025-acc6d80e,
  author  = {Cohen, S. and Ducharme, S. and Brosch, JR. and others},
  title   = {{Multiple-Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid-Beta Precursor Protein for Alzheimer's Disease}},
  journal = {Alzheimer's \& Dementia (AAIC 2025 conference abstract)},
  year    = {2025}
}

@article{sciences2024-e69e4b94,
  author  = {Sciences, Cassava},
  title   = {{Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints (ReThink-ALZ)}},
  journal = {GlobeNewswire (company press release); trial registered as NCT04994483},
  year    = {2024}
}

@article{mulhern2013-23402232,
  author  = {Mulhern, B. and Rowen, D. and Brazier, J. and Smith, S. and Romeo, R. and Tait, R. and Watchurst, C. and Chua, K. C. and others},
  title   = {{Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation}},
  journal = {Health technology assessment (Winchester, England)},
  year    = {2013},
  doi     = {10.3310/hta17050},
  pmid    = {23402232},
  url     = {https://doi.org/10.3310/hta17050}
}

@article{day2022-35197360,
  author  = {Day, G. S. and Scarmeas, N. and Dubinsky, R. and Coerver, K. and Mostacero, A. and West, B. and Wessels, SR. and Armstrong, M. J.},
  title   = {{Aducanumab Use in Symptomatic Alzheimer Disease Evidence in Focus [RETIRED]: A Report of the AAN Guidelines Subcommittee}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000200176},
  pmid    = {35197360},
  url     = {https://doi.org/10.1212/wnl.0000000000200176}
}

@article{hey2026-a02492d7,
  author  = {Hey, J. A. and Geerts, H. and Schaefer, J. F. and Short, S. M. and Graaf, P. and Abushakra, S. and Power, A. and Tolar, M. and others},
  title   = {{Quantitative Systems Pharmacology Analysis of Amyloid Aggregation and Hippocampal Atrophy Trajectories in Alzheimer’s Disease by APOE4 Genotype and Valiltramiprosate/ALZ-801 Treatment}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10570608/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10570608/v1}
}

@article{heidari2026-8aa9046f,
  author  = {Heidari, A. and Aghajani, M.},
  title   = {{APOE ε4 Carrier Status and Cognitive Decline in Mild-to-Moderate Alzheimer’s Disease: A Linear Mixed-Effects Analysis of the Placebo Arm of EXPEDITION 1}},
  journal = {medRxiv},
  year    = {2026},
  doi     = {10.64898/2026.09.27.26364131},
  url     = {https://doi.org/10.64898/2026.09.27.26364131}
}

@article{jaeger2025-377d6a5b,
  author  = {Jaeger, J. and Staats, K. A. and Barnum, S. and Pope, P. and Kingery, L. and Buitendyk, M. and Cohen, S. and Tansey, M. G. and others},
  title   = {{XPro1595, a Selective Soluble TNF Neutralizer, in Early Alzheimer’s Disease with Inflammation (ADi): Results from the Phase 2 MINDFuL Trial}},
  journal = {medRxiv},
  year    = {2025},
  doi     = {10.1101/2025.09.24.25336496},
  url     = {https://doi.org/10.1101/2025.09.24.25336496}
}

@article{sulter2026-7e0e4d07,
  author  = {Sulter, G. A.},
  title   = {{Reversibility and Access: A Two-Axis Framework for Glucagon-Like Peptide-1 Receptor Agonists Across the Neurological Spectrum, and a Falsifiable Analgesic Hypothesis for Chronic Migraine}},
  journal = {Preprints.org},
  year    = {2026},
  doi     = {10.20944/preprints202607.1279.v1},
  url     = {https://doi.org/10.20944/preprints202607.1279.v1}
}

@article{aversi2026-24e6bbda,
  author  = {Aversi, M. T. M. and Freitas, P. M. and Aversi-Ferreira, T. A.},
  title   = {{New Alzheimer’s Disease Diagnostics and Psychological Clinical Perspectives}},
  journal = {PsyArXiv},
  year    = {2026},
  doi     = {10.31234/osf.io/sz4ay_v1},
  url     = {https://doi.org/10.31234/osf.io/sz4ay_v1}
}